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Interplay of G Protein-Coupled Receptors with the Membrane:
Insights from Supra-Atomic Coarse Grain Molecular Dynamics
Simulations
Xavier Periole*,†
Biomolecular Sciences and Biotechnology Institute and Zernike Institute for Advanced Materials, University of Groningen,
Nijenborgh 7, 9747AG Groningen, The Netherlands
ABSTRACT: G protein-coupled receptors (GPCRs) are central to many fundamental
cellular signaling pathways. They transduce signals from the outside to the inside of cells
in physiological processes ranging from vision to immune response. It is extremely
challenging to look at them individually using conventional experimental techniques.
Recently, a pseudo atomistic molecular model has emerged as a valuable tool to access
information on GPCRs, more speciﬁcally on their interactions with their environment in
their native cell membrane and the consequences on their supramolecular organization.
This approach uses the Martini coarse grain (CG) model to describe the receptors,
lipids, and solvent in molecular dynamics (MD) simulations and in enough detail to
allow conserving the chemical speciﬁcity of the diﬀerent molecules. The elimination of
unnecessary degrees of freedom has opened up large-scale simulations of the lipid-
mediated supramolecular organization of GPCRs. Here, after introducing the Martini CGMD method, we review these studies
carried out on various members of the GPCR family, including rhodopsin (visual receptor), opioid receptors, adrenergic
receptors, adenosine receptors, dopamine receptor, and sphingosine 1-phosphate receptor. These studies have brought to light an
interesting set of novel biophysical principles. The insights range from revealing localized and heterogeneous deformations of the
membrane bilayer at the surface of the protein, speciﬁc interactions of lipid molecules with individual GPCRs, to the eﬀect of the
membrane matrix on global GPCR self-assembly. The review ends with an overview of the lessons learned from the use of the
CGMD method, the biophysical−chemical ﬁndings on lipid−protein interplay.
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Transmembrane signaling through G protein-coupled recep-
tors, GPCRs, is involved in many fundamental biological
processes. GPCR signaling is initiated by the activation of the
transmembrane receptor (R) by an extracellular stimulus,
followed by the binding of its cognate G protein on the
intracellular side triggering the exchange of GDP for GTP
within the G protein, which in turn leads to a multitude of
intracellular chain reactions.1
Understanding GPCR signaling is an inherent multiscale
problem. On one end of the scale, structural details of the
activation mechanism of both the receptor (R) and the G
protein (G) are important as emphasized by numerous recent
studies using extensive dedicated experimental and computa-
tional resources on the conformational states of R,2−6 G,7,8 and
R−G,9,10 picturing a dynamic process.5,11−14 In addition, high-
resolution spectroscopy and computational studies have looked
into the details of ligand binding in relation to activa-
tion.12,15−18 On the other end of the scale, receptor signaling
may be described on a cellular level using a system biology
approach based on analytical models.19−22 These models have
recently been dealing with the incorporation of GPCR
oligomerization.19
The challenge of connecting the atomically detailed scale to
the system’s level remains. Additional methods have emerged
to probe this intermediate range of length and time scales. In
the ﬁeld of conventional experiments, labeling and single-
molecule methods have shown a lot of progress; for a recent
review see ref 23. In the ﬁeld of computational modeling, coarse
grain molecular dynamics (CGMD) has become an important
tool to study biomolecular processes,24−26 including the lateral
organization of membrane proteins.27
In this review, we focus on CGMD studies of GPCRs based
on the Martini model,28 which, as we will show, has proven to
be a very powerful tool to study GPCR signaling. The nature of
the model is speciﬁcally pertinent to length and time scales
where protein−lipid interplay is important and therefore makes
it unique for this type of studies. Although other CG
approaches exist none have been used in the study of GPCRs
in lipid membrane with such resolution. The applications using
the model have concentrated on the eﬀect of lipid−protein
interactions on GPCR behavior in biological membranes.
GPCR oligomerization state is at the heart of most of the
studies discussed in this review since it has been shown to aﬀect
their function quite dramatically, although the relevance in vivo
is still a matter of debate.29−32
We ﬁrst describe the foundations of the Martini CG in MD
simulations (referred to as Martini CGMD method, including
the associated MD setups typical of such simulations) and
associated techniques, underlining the potential of this
approach and the main limitations. Then we describe in detail
a few series of articles, which were grouped by theme but often
coincide with the laboratory of origin and a few more isolated
studies. We follow by discussing the lessons collectively learned
on both the methodological and the membrane protein
biophysics principle perspectives. We end the review with
short concluding remarks and perspectives in the ﬁeld.
Other recent reviews in this ﬁeld include reviews on the
progress of molecular dynamics simulations for the study of
GPCRs,33−35 a review of more general computational methods
for predicting the structure of GPCRs and their interactions
with ligands with an emphasis on allosteric issues, biased
signaling and oligomerization,36 reviews covering the diﬀerent
length and time scales relevant to GPCR signaling,37,38 and
some reviews on GPCRs related to their interactions with the
membranes.39,40 Others have focused on the simulation of
biomembranes at both atomistic and CG resolutions.27,41
2. MARTINI CGMD SIMULATIONS: THE METHOD
2.1. Martini Coarse Grain Model for GPCR
2.1.1. General Features of the Martini Model. The
Martini coarse grain (CG) force ﬁeld is an extremely versatile
model currently most adapted to biological systems.42,43 It has
rapidly gained popularity since its ﬁrst use on simple lipidic
systems.42,44 The success of the model rests on its grounding
on simple and intuitive physicochemical principles, which make
it easily transferable to a wide range of systems and ﬁelds from
biochemistry to materials sciences.28 The model has recently
been applied to complex systems such as mimics of realistic
biological membranes with up to 62 diﬀerent lipid types and
proteins.45,46
As a CG model, Martini reduces the resolution of the
representation of a system of interest by discarding degrees of
freedom (DoF). It is understood that the questions under
investigation with such model must not strongly depend on
those DoF. In a similar manner, as atomistic models neglect the
electronic DoF, the Martini model averages atomic properties
to chemical entities and neglects individual atoms. Its resolution
is supra-atomic, with on average four heavy atoms (non-
hydrogen) and associated hydrogens grouped together into
superatoms or CG beads.
The simplicity of the Martini model relies on the deﬁnition
of a limited set of building blocks: 19 diﬀerent types of CG
beads, covering chemical group properties from superpolar to
very hydrophobic.43 The transferability relies on the para-
metrization of those building blocks using thermodynamic data,
in particular, the partitioning free energy of the CG beads
between various media with diﬀerent polarity or hydro-
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phobicity. The propensity of chemical groups (building blocks
for larger biological molecules) to partition in diﬀerent
environments, in combination with more speciﬁc interactions,
is at the heart of many biophysical processes.47 In the Martini
model the (nonbonded) interactions use simple Lennard−
Jones potentials and are deﬁned by what we call the
“interaction matrix”.43
For molecules for which the mapping requires more than a
single bead (lipids, ligands, amino acids and proteins,
nucleotides and DNA, etc.), eﬀective bonded potentials are
built such that the geometrical features and the conformational
ﬂexibility of that particular molecule, as observed in simulation
at the atomistic resolution or experiments, are reproduced.48
Bead-type assignment (typography) is then determined and
reﬁned to reﬂect partitioning data and energy proﬁles if
available.48
Topologies for the Martini model are now available for a
large variety of lipids,43,49 amino acids,50 sugars,51 nucleotides,52
fullerene,53 and polymers,54,55 and tools have been developed
to build topologies for lipids, proteins, and DNA and construct
systems where they are mixed.49 These scripts are accessible on
the Martini Web site (cgmartini.nl). More details about the
Martini model can be found in our original papers42,43 and
reviews.24,28,48 Examples of the Martini topology for a typical
lipid, peptide, and a GPCR are shown in Figure 1.
2.1.2. ElNeDyn Approach for Proteins. A current
limitation of the Martini CG force ﬁeld is the lack of a
systematic representation of the directionality of interactions
between polar groups. This aspect of molecular interactions is
important for small local dipole−dipole interactions such as
hydrogen bonds.56 H-bonding directionality is of particular
importance for the protein backbone stability.57−59 The
secondary structures elements such as α-helices and β-sheets
entirely depend on them. Implementations of local dipoles in
Martini have been used to mimic the electrostatic shielding of
water60 and to improve the behavior of polar amino acid side
chains,61 but a satisfactory approach for the protein backbone
has not yet emerged. Thus, the use of additional constraints is
mandatory to maintain the secondary and in most cases the
ternary structure of proteins. Bond and Sansom ﬁrst introduced
Figure 1. Mapping of the Martini coarse grain force ﬁeld. (A) Mapping examples for a few biological molecules: 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine, DPPC; water; a protein helical fragment in atomistic (AA) and CG resolutions. In the three cases, the AA resolution is depicted as
ball and stick and the CG resolution by the underlying bond structure in black sticks with the beads or super atoms as transparent van der Waals
spheres. In the CG helical fragment, the backbone beads are highlighted by red full spheres. The type of bead is indicated in gray on the side of the
beads. Adapted from ref 48 with permission. Copyright 2013 Springer. (B) CG model of a GPCR, rhodopsin. The atomistic structure is shown as a
cartoon with the seven helical segments colored magenta, the sheets on the extracellular side (top) of the protein in yellow, and the loops in gray. A
transparent surface is used to indicate the van der Waals space occupied by the protein. The coarse grain model is shown using van der Waals spheres
for all beads. The color code indicates the polarity of the beads as deﬁned in the model.50 The elastic network used in the ElNeDyn approach65 is
shown together with the trace of the protein (black sticks). The graph reports the root-mean-square-deviation (RMSD) of the rhodopsin relative to
its starting structure using either the standard Martini model version 2.150 or the ElNeDyn approach.65
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the idea of using an elastic network (EN, a set of strings
connecting the protein backbone interaction sites) to maintain
the fold of a protein62,63 in their pioneering work on using the
Martini CG to study protein/lipid interplay.64
Systematic parametrization of the Martini EN was sub-
sequently performed in our group and coined ElNeDin for
Elastic Network en Dinamica ́ (Spanish for in dynamics).65
ElNeDyn (English version) is now a very standard protocol for
proteins consisting of more than a few interacting helices. See
Figure 1B for an illustration on a GPCR. Typically β-sheets are
extremely deformable in standard Martini, while α-helices
require strong bonded terms.50 More sophisticated ENs have
been developed to better capture the complexity of some
Figure 2. Typical systems used in Martini CGMD simulations of GPCRs. (A) Single receptor embedded in lipid bilayer. Views from the
extracellular, cytoplasmic, and membrane side are shown. This system is typically used to study the details of the protein/membrane interactions,
such as membrane deformation and lipid binding sites. Lipids are shown in gray, white, and blue stick for the tails, glycerol backbone, and head,
respectively. Water phase is omitted in the extracellular and cytoplasmic views and shown as blue spheres in the side view. (B) Sixteen receptors
embedded in a membrane bilayer. Starting structure (t = 0 μs) with random orientations of the receptors is depicted together with the progression of
the systems in time depicted by snapshots at 4, 12, and 20 μs*. (C) Sixty-four receptors embedded in a membrane bilayer after 100 μs* of self-
assembly. (D) Two receptors embedded in a lipid bilayer. This system is commonly used in the determination of PMF using the umbrella sampling
(US) approach with the weighted histogram analysis method (WHAM). In the US the distance between the proteins, d, and their relative
orientations, ϕ1 and ϕ3, is controlled using harmonic potentials in order to probe deﬁned interfaces. This is done by the virtual bond algorithm
(VBA), which deﬁnes a distance and two dihedral angles, ϕ1 and ϕ3, or alternatively two angles. See the Methods and Systems section for details.
Dimensions of the systems are indicated. Systems were constructed using rhodopsin as receptor. In A−C, these proteins are depicted by orange
tubes positioned at the location of the 7 transmembrane helices and the helix 8 is shown in black. In A, the lipids are shown in gray. In B and C,
periodic boundary conditions are shown in gray with the proteins in green. Protein:lipid ratios were 1/466, 1/328, and 1/100 in the monomeric (A),
dimeric (D), and 16- (B) and 64-meric (C) structures. (B−D) Modiﬁed from Periole et al., ref 81, with permission. Copyright 2012 American
Chemical Society. (E) One hundred forty-four S1P1 receptors embedded in a plasma membrane-like composition. Reproduced with permission from
ref 46. Copyright 2015 American Chemical Society. (F) Rhodopsin (yellow) in a lipidic cubic phase used by Khelashvili et al. to estimate the residual
hydrophobic matching on rhodopsin surface. Reproduced with permission from ref 78. Copyright 2012 American Chemical Society.
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protein ﬂexibility, e.g., a virus capsid,66 membrane proteins,67
and more recently GPCRs, μOR,68 and CXCR4.69
2.1.3. Note on the Martini CG Time Scale. In the
parametrization of Martini molecules in general and for the EN
in particular, it is important to match the time scales of the
(atomistic) simulationson which the EN parameters are built
uponwith the CG simulation. The time scales in CG models,
their dynamics, are increased in most cases relative to atomistic
models. Notably, the removal of atomistic frictions will
smoothen the free energy landscape. A factor of 4 was derived
from the increase of water diﬀusion and alkyl chains
conformational dynamics.42,43,70−72 Accordingly, a similar
scaling factor was used to collect ﬂuctuations in atomistic
simulations and compare them to CG simulations to building
an EN4 times longer AA than CG simulations are required.
Using a diﬀerent value for this factor will aﬀect the ratio of
conformational ﬂexibility and dynamics of the CG protein vs
the lipids chains and, in turn, might aﬀect the heat transfer
between them. This change might be most directly pictured in
the loop regions of proteins. However, as an elastic object the
protein might also react diﬀerently in response to pressure from
a membrane bilayer or other external forces. These eﬀects have
not been systematically quantiﬁed and might be minor. In this
review, time using the factor 4 are indicated by an asterisk (*).
2.2. Methods and Systems
In this section, we quickly describe the techniques that have
been used, in conjunction with the Martini CG model, in the
articles discussed in this review.
2.2.1. Molecular Dynamics Simulations. Molecular
dynamics (MD) simulations in general but of biological
systems in particular have tremendously evolved since their
early start.73,74 Developments of both computer technologies
and algorithms eﬃciency have contributed to this progress. The
Martini CG model has been originally developed for the
GROMACS software,75 a versatile user-friendly package
dedicated to high-throughput MD simulations and analysis.
Implementations are also available for NAMD,76 GROMOS,72
and Desmond.77
A standard MD simulation is literally and simply the
propagation of a system in time. This numerical performance
is achieved by iteratively integrating the equations of motion
Newton’s second law. The particles of the system move
according to forces acting on them at a given timedescribed
by a force ﬁeld and thus resulting from the interactions between
them. The trajectory of a system constitutes the raw data, and
only its analysis reveals the system’s behavior. The quality and
sophistication of the analysis of the trajectory are therefore
determinant.
The MD simulation of a system is deﬁned by its
conﬁguration and the thermodynamic state it is performed in
(temperature, pressure, etc.), but it also depends on the starting
conformation of the system as it will often only explore a
restricted region of the phase space. CG models and Martini, in
particular, are attempts to alleviate this limitation by reducing
the number of DoF and allow the system to explore more
systematically equilibrium conditions. This has been illustrated
by keystone simulations such as the formation of complex lipid
phase in early Martini studies42,44 and more recently on a
multitude of systems.28
In the review, we use the Martini CGMD simulation/method
to refer to the use of the Martini CG model in MD simulations,
which includes the typical setups of such simulations. A CGMD
simulation, however, is not a diﬀerent technique than regular
MD simulations.
2.2.2. Systems. Most of the studies discussed in this review
have used relatively simple systems, which are summarized in
Figure 2. The simpler system consists in a receptor embedded
in a membrane bilayer. The bilayer composition may range
from a single lipid component to a more sophisticated mixture
aiming at mimicking native membrane compositions. Details
are given for each study when appropriate. A single-receptor
system is typically used to characterize the interplay between
speciﬁc lipid molecules, the bilayer matrix, and the receptor.
Lipid binding sites, membrane adaptation to the presence of a
receptor, lipid, and receptor lateral mobilities may be
determined. This simple system is often used as a unit cell to
build more complex or crowded ones.
Khelashvili and co-workers used a system notably diﬀerent
from the common lipid bilayer. They built a lipidic cubic phase
(LCP) with monoacylglycerol molecules and characterized its
geometrical properties for three diﬀerent chain lengths,
composition, and temperature (Figure 2F).78,79
2.2.3. GPCR Self-Assembly Simulations. Self-assembly
simulations have been part of the Martini CGMD studies of
GPCRs from the start80 and have been regularly used since
then.81−86 This type of simulation aims at studying a system in
which multiple receptors coexist, as in membranes. They
consist in embedding a large number of receptors (2−144) in a
preformed lipid bilayer and regularly spaced to maximize their
dispersion in the membrane (Figure 2B), often built from the
repeat of a unit cell containing a single receptor. From that
dispersed conﬁguration one may follow the assembly of the
receptors. Unfortunately, on the time scale accessible to the
Martini CGMD simulations, it is mainly the association of the
receptors that is observed. Only limited events of dissociation
have been reported. The supramolecular organization of the
receptors described by Martini CGMD simulations on time
scales up to 100 μs is most likely not representative of
biological time scales and their complex dynamics in
physiological conditions. A more realistic lipid composition
would also be beneﬁcial. These self-assembly simulations are
typically out-of-equilibrium simulations. However, they provide
extremely valuable information on the receptor behavior in a
lipid bilayer, e.g., their propensity to oligomerize, the interfaces
that are accessible, and the kinetics of the contacts. The
comparison of simulations performed with diﬀerent conditions,
e.g., lipid composition (thickness, viscosity) and receptor,
allows one to characterize the oligomerization pattern
pertaining to lipid/receptor interplay.46,80−86
In the search for relevant protein−protein contacts,
Wassenaar et al. developed a protocol, “docking assay for
transmembrane components” (DAFT),87 to predict eﬀectively
the most accessible interfaces of transmembrane (TM) helices
and proteins. DAFT is a clever way to setup systematic self-
assembly simulations of proteins/peptides. It consists of
automatically setting up a large number of simulations with
the molecules randomly oriented and embedded in a lipid
bilayer. The protocol was tested with the Martini force ﬁeld and
uses MD simulations with the associated setup. It can extend to
systems with up to nine diﬀerent protein monomers assuring
the best-starting structures with optimized periodic boundary
conditions to sampling partners’ interfaces. The protocol was
validated on simple transmembrane helices and the GPCR
rhodopsin. The results showed that for a simple system such as
a transmembrane helix (glycophorin A) with a unique dimeric
Chemical Reviews Review
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interface the method is able to reliably predict the complex and
the eﬀect of debilitating mutant. It was also able to predict the
trimeric arrangement of the GCN4-derived peptide MS1, a
transmembrane helix. For more complex systems such as
GPCR oligomerization where multiple interfaces may form,
DAFT, as regular self-assembly simulations, has diﬃculties to
generate interfaces with populations reﬂecting their relative
thermodynamic stability. The protocol relies on a large number
of short (∼1 μs) simulations that can only capture events
accessible on that time scale.
The lack or limited amount of binding/unbinding events in
self-assembly simulations in general but of GPCR in particular,
by deﬁnition, precludes the access to thermodynamic quantities
such as the relative binding free energies of speciﬁc interfaces.81
Another point to consider when interpreting the populations of
interfaces obtained from self-assembly simulations is a possibly
strong kinetic contribution to the receptor approach. This point
was recently clearly demonstrated by Provasi et al.,85 see below.
Nevertheless, self-assembly simulations have revealed
important lipid/protein interplays and will continue to be of
great use. The combination of self-assembly simulations of
multiple receptors revealing cooperative features and supra-
molecular organizations80−82,85,86 and DAFT generating more
systematic information on accessible interfaces will be of
interest to GPCRs41 but also for other transmembrane
proteins.88,89
2.2.4. Biased Simulations: US/WHAM and Metady-
namics. An area of great interest for GPCRs is the search for
structural keys to the supramolecular organization of rhodopsin
or the oligomerization pattern of GPCRs. The interfaces
involved in contacts between receptors and their associated
strength (relating to their binding free energy) are central in
that matter. In principle, the relative strength of protein
interfaces can be extracted from the radial distribution function
(RDF) or the potential of mean force (PMF; RDF(r) =
exp[-PMF(r)/kBT]) computed from an unbiased simulation.
However, the simulations must have sampled the conforma-
tional space accessible to the system at equilibrium. In the
present case, that means binding and unbinding events of all
possible protein interfaces. This degree of convergence is not
yet accessible within the current time scale of Martini CGMD
simulations. The self-assembly described above provides great
information about the interfaces but not their relative strength.
Alternatively, one can determine the potential of mean forces
(PMF) between two receptors using the umbrella sampling
(US) technique.90 It discretizes the reaction coordinate, the
distance between receptors, into bins that are explored
independently using a biasing umbrella potential to maintain
the distance close to the value at each bin (umbrella window)
and assuring overlap between consecutive bins. The deviation
from the ideal distribution of the distance reﬂects the
(un)stability of the system in that particular window, and the
knowledge of the biasing potential allows one to generate
unbiased distributions corresponding to each umbrella window.
These are combined afterward using the weighted histogram
analysis method (WHAM).91−93
Filizola and co-workers and Periole and co-workers used this
approach on opioid receptors and on rhodopsin, respectively
(see below), with similar strategies to explore particular
interfaces. The relative orientations of the proteins were
“restrained” using additional harmonic potentials but with
slightly diﬀerent restraining potentials on the protein
orientations.37 The dihedral angle restraints used by Periole
and co-workers (part of the virtual bond analysis, VBA,94 Figure
2D) present the advantage to cover the full range of protein
orientations and avoid redundancy (Figure 4). Periole and co-
workers used a six-dimensional WHAM (although only 3 were
actively used) to be able to correct for these additional biases in
the ﬁnal PMF.81
Filizola and co-workers added a layer of sophistication to the
characterization of the GPCR interfaces. They used well-
tempered metadynamics95 to enhance sampling when generat-
ing starting conﬁgurations and free energy maps of the relative
orientation of the receptors and also combined with the US
technique at each umbrella simulation. Well-tempered meta-
dynamics adds Gaussian biases onto deﬁned collective variables,
here angles maintaining the receptor orientations to remove
energy barriers along them. The biases might be collected and
used to reconstruct the free energy proﬁle along the collective
variables. Filizola and co-workers also corrected for the use of
metadynamics when combined with US.96
3. MARTINI CGMD SIMULATION STUDIES ON GPCRS
In this section, we review the studies that have used the Martini
CGMD simulation approach and added techniques described
above to study GPCRs. These studies have mostly been
performed in a handful of laboratories keeping the technique
quite close to the original one so that it is easier to relate them.
Toward the end of this section we review a few more recent
and isolated studies that further illustrate the exciting potential
of the CGMD approach for GPCRs.
3.1. Rhodopsin Supramolecular Organization
The Martini CGMD simulation venture into the exploration of
GPCR signaling was pioneered by the study of the supra-
molecular organization of rhodopsin,80 a light-sensitive receptor
involved in the visual phototransduction. This study was
motivated by the report of an intriguing highly ordered
organization of the photoreceptor in rod outer segments
(ROS) disc membrane from AFM images.97 Furthermore, our
colleagues from Sakmar’s laboratory at Rockefeller University/
NYC and Brown’s laboratory from the University of Arizona at
Tucson were able to strictly correlate the spatial distribution of
rhodopsins in model membranes with their photoactivation.98
Of particular interest was the similar response of rhodopsin’s
spatial organization (FRET eﬃciency) and photoactivation to
the change of membrane thickness. The results strongly
suggested that the hydrophobic mismatch between the
receptors and the lipid bilayer governs their degree of
association and thereby their activation.
A ﬁrst set of Martini CGMD simulations80 described the self-
assembly of 16 rhodopsins embedded in a lipid bilayer with a
range of thicknesses matching the experimental data.98 The
receptors were observed to spontaneously self-assemble and
doing so to a degree depending on the membrane thickness, in
perfect agreement with the experimental data from Botelho et
al. A maximal dispersion of the receptor was observed for an
intermediate lipid thickness matching the hydrophobic thick-
ness of rhodopsin, while thinner and thicker bilayer increased
the receptor’s propensity to form contacts. The correlation
between the hydrophobic mismatch and the assembly
propensity of the receptor was not a complete surprise to
either experimental or computational approaches as hydro-
phobic mismatch had been pointed out as a driving force for
membrane protein association in general99 and for rhodopsin in
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particular.98 The Martini CGMD simulations matched quite
well the FRET signal reported earlier.
An exiting novel ﬁnding of the CGMD study was the
demonstration of nonhomogeneous membrane deformation
around the protein (Figure 3A and 3B), i.e., the membrane
bilayer adapted to the protein/membrane interface variably at
diﬀerent regions of the protein surface. In addition, the regions
of the protein surface where the membrane deformed varied
with the thickness of the membrane; in other words, the
protein/membrane interface heterogeneity varied with the
hydrophobic thickness of the membrane. Of particular note was
that the regions on the protein surface where the membrane
deformed the most in response to hydrophobic mismatch
strongly correlated with the location where the protein was
seen making protein−protein contacts upon self-assembly. At
that point the details of the protein−protein contacts were not
analyzed, as the statistical relevance was considered not
suﬃcient to be conclusive.
On the basis of the assumption that protein/membrane
hydrophobic mismatch drives integral protein assembly by
reducing the membrane deformation,99 these results suggested
that protein contacts would form favorably at speciﬁc locations
of the protein surface and that these locations might vary with
the membrane thickness. While the former interpretation has
been conﬁrmed by several approaches (see below), the latter
has not yet been observed.
Figure 3. Heterogeneous deformation of the membrane at the surface of GPCRs. (A and B) Membrane deformations observed in CGMD
simulations of rhodopsin monomers in four diﬀerent lipid compositions varying the thicknesses of the bilayer. Reproduced with permission from ref
80. Copyright 2007 American Chemical Society. (A) Occupation density of the glycerol beads shown in gray surface maps around the rhodopsin
shown in dark blue. Arrows point to the most prominent deformations. (B) Projected bilayer thickness onto the membrane plane. Color code
follows the bilayer thickness, and orientation of the rhodopsin is shown. (C) Deformation of the membrane around rhodopsin as observed in
atomistic MD simulations. Reprinted from ref 100 with permission. Copyright 2011 Elsevier. Color code here indicates the deformation from the
average membrane bulk thickness. Orientation of rhodopsin is similar as in A and B.
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Inhomogeneous membrane deformation around rhodopsin
was conﬁrmed by atomistic resolution MD simulations (Figure
3C).100 On the basis of the analysis of these higher resolution
simulations the authors described the free energy associated
with the presence of an hydrophobic mismatch between the
surface of the protein and the lipid bilayer thickness as the sum
of two main components: the membrane deformation to match
the hydrophobic surface of the protein to the best of its abilities
and the residual hydrophobic mismatch (RHM) occurring
when the protein remains exposed to an unfavorable environ-
ment. The residual hydrophobic mismatch was found to be an
important contribution to the system free energy. See below for
more details on the studies from Weinstein, Khelashvili, and co-
workers on the membrane/protein interplay.39,40
In a follow-up study, Periole et al.81 probed more speciﬁcally
the relative strength of diﬀerent interfaces in rhodopsin dimers.
This work was intended at building a model of rhodopsin
organization in its native environment, the ROS disc
membrane, depicted by AFM images97 as a highly ordered
set of rhodopsin row-of-dimer. The details of the interfaces
could not be resolved from the AFM data, and the nature of the
dimer interface remained highly debated. A row-of-dimers
model was built based on the images that showed a symmetric
TM4/5 rhodopsin dimer.101 This apparent static arrangement
of rhodopsins was quite controversial as apparently contra-
dicting earlier biophysical experiments.102 However, it was
extremely exciting to have access to structural data relating to
the supramolecular organization of rhodopsin in native
conditions and build models to reveal their interactions at a
pseudo atomistic resolution.
Periole et al.81 probed rhodopsin interfaces using two
complementary approaches: self-assembly simulations, similar
to the earlier study,80 and calculation of the potential of mean
force (PMF) as a function of the receptor separation (Figure
4). While the ﬁrst approach allows observing the formation and
characterization of the interfaces most accessible to the
receptors as they assemble on the time scale simulated, the
second approach allows a precise quantiﬁcation of the relative
strength of the interfaces. Ideally, one would use the ﬁrst type
of simulations (multiple replicas) from which potential
interfaces may be identiﬁed, and subsequently, the second
method may be used to compare them.
The self-assembly simulations were carried out using
conditions where the receptor interactions would be the least
aﬀected by the membrane deformation due to the presence of a
hydrophobic mismatch.80 The simulations conﬁrmed the
preferential linear arrangement of rhodopsins when embedded
in a membrane bilayer and revealed a few preferential interfaces
(Figure 2B and 2C). The interfaces involving TM1 and H8
(simultaneously) or TM5 combined symmetrically and asym-
metrically were predominantly formed. The interfaces involving
the other sides of rhodopsin, around TM4 and TM6, did not
form in a signiﬁcant amount. The PMFs rationalized these
observations. The limited formation of interfaces centered on
Figure 4. Relative strength of GPCR interfaces probed by PMFs. (A) Illustration of the most prominent interfaces observed in GPCRs shown from
the cytoplasmic side. Rhodopsin is used as a GPCR model. (B) Map of the interfaces onto the structure of rhodopsin view from the cytoplasmic side.
Beside the name given to the interfaces it also gives the relation between the interfaces and the restraints used in VBA. A similar map could be built
based on the method used by Filizola et al. (C, D, and E) PMFs of opioid and adrenergic receptors and rhodopsin, respectively. In all panels the
individual interfaces are color coded. Data was extracted from the studies from Filizola and co-workers114−116,96 and Periole and co-workers.81
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TM4 and TM6 was due to the presence of an energy barrier to
their formation (Figure 4E). This energy barrier resulted from
the trapping of lipids at the interface and the stabilization of a
metastable state where lipids lubricate the interface. The
interfaces forming in the self-assembly simulations (TM1/H8
and TM5) did not show an energy barrier to their formation
(Figure 4E). The PMFs led to the deﬁnition of two types of
interfaces: some weak with an energy barrier to their
spontaneous formation and others strong with a deep minimum
at the interface and no energy barrier to complexation (Figure
4E).
Interestingly, the PMFs demonstrated a striking stability of
the symmetric TM1/H8 dimer interface compared to the other
interfaces probed, an interface long discarded for the small size
of protein burial associated with it.103 It was however not a
complete surprise as this interface had previously been
observed in two-dimensional104 (2D) and three-dimensional105
(3D) electron microscopy (EM) and X-ray crystallography of
opsin, rhodopsin, and metarhodopsin I and II.106−108 This data
motivated an earlier study in which we were able to show that
the symmetric TM1/H8 interface existed in the native
membrane based on a combination of chemical cross-linking
experiments, partial proteolysis, and high-resolution liquid
chromatography-mass spectroscopy.109 Many other GPCRs
have also been crystallized with the TM1/H8 interface.110−112
On the basis of the TM1/H8 rhodopsin dimer interface it
was possible to construct a row-of-dimer model that fulﬁlled
the structural feature extracted from the AFM images. In
addition to the TM1/H8 dimer interface, this model also
complied with the existence of lubricated interfaces, centered
on TM4 and TM6, that would stabilize interfaces between two
dimers in a row. We further discuss this organization later on.
On a biophysical perspective on protein/membrane inter-
play, the stability of the TM1/H8 interface in the rhodopsin
dimer is of primary importance, because it has a smaller protein
burial than the others. It is actually quite systematic that within
the interfaces probed the strong ones have smaller burial than
the weak ones (Figure 4 A and 4E and ref 81). This observation
strongly challenges the use of buried accessible surface area as a
predictor of the strength of membrane-embedded protein−
protein interfaces. Other forces must apply. We found a few
amino acid interactions forming networks at the interface. One
study recently suggested that the residual hydrophobic
mismatch might be a signiﬁcant contribution to GPCRs
interface stabilization (see section 3.3 for more details).
3.2. Rationalization of Opioid Receptors Oligomerization
Filizola and co-workers, inspired by the Martini CGMD
simulation technique80 described above and its combination
with metadynamics95 to enhance sampling, published a nice
series of studies probing GPCR interfaces. They emphasized on
δ-, μ-, and κ-opioid receptors (OR). These studies were a
logical continuation of their previous interest in the
determining GPCR interfaces.113
They started by characterizing the binding proﬁle of the δ-
opioid receptor (δOR) at the TM4 (also referred to as TM4/3)
interface calculating the ﬁrst PMF of a GPCR interface.114 They
subsequently compared it to the PMF of the TM4/5 interface,
allowing them to rationalize cross-link experiments.115 The
receptors were embedded in a POPC lipid bilayer with 10%
cholesterol, and for the model of δOR they used a similar
approach to that developed for rhodopsin.65,80 Only the EN
deﬁning the framework of the protein was modiﬁed to give
more conformational ﬂexibility to the loop regions.114 Although
the sampling might have been slightly limited due to short
simulation times accessible at the time (as shown by the
roughness of the PMF curves, Figure 4C), these PMFs
provided a fascinating view of the interfaces proﬁle and their
relative strength. The simulations gave the TM4 (or TM4/3)
interface of δOR as favorite compared to the TM4/5 interface.
However, both interfaces had no energy barrier to binding
(Figure 4C), and the free energy stabilization in the dimer
conﬁguration suggested a half-life time on the order of seconds,
0.2 and 4.4 s for TM4/5 and TM4 (or TM4/3), respectively.
In a later study, Johnston and Filizola extended their work on
OR using PMFs to look at interfaces of μOR and κOR as found
in the crystallographic structures.116 These include the TM1/
H8 for both receptors and the TM5/6 for μOR. The TM1/H8
interface uses contacts of TM1 on the side of TM2, similar to
the case of rhodopsin. The results show that the symmetric
interface involving TM5/6 is more stable than the one
involving TM1/H8 and by a signiﬁcant amount when
compared to the other interfaces and other receptors (Figure
4C). The TM1/H8 interface of μOR has a similar strength as
the TM1/H8 interface of other GPCRs (β1AR and β2AR,
described below and using the TM7 side of TM1 for contacts;
Figure 4B). Striking is the increase of the TM1/H8 interface
stability for κOR by a factor close to 5 in terms of depth of the
free energy well compared to μOR (Figure 4C). The authors
attributed this increase to a diﬀerent conformation of the
helices 1, 2, and 8 in the two receptors. TM1 is pointing away
from the helical bundle in κOR, while it is close to it in μOR as
in most receptors. This observation is a clear illustration that
the local structure of the receptor determines the interaction
between them, adding to the importance of the details of an
interface in determining its strength.
In their most recent work on OR, Provasi et al.85 used the
self-assembly approach to looking at the interfaces preferen-
tially formed by three receptors from the opioid subfamily they
have studied previously using PMFs: δOR, μOR, and κOR.
They investigated homomeric complexes for the three
receptors and heteromeric between the pairs δOR/μOR and
δOR/κOR. As noted by the authors, although this approach
does not allow the calculation of free energies and thereby
prevents the comparison of the relative strength of the
interfaces formed (based on their populations) as with
PMFs,81 it reveals the interfaces accessible on the time scale
simulated. In all ﬁve systems the opioid receptors formed
ﬁliform (elongated) structures using the small sides of the
receptors: centered either on TM1/2 or TM5 alone and
combined with TM4 or TM6 (Figure 4B). Signiﬁcant
populations of symmetric interfaces were observed only in
the cases of TM1/2/H8 and TM5. The frequency of
appearance of the interfaces depends on the receptors
simulated, but their conﬁdence intervals were broad, and the
diﬀerences might not be signiﬁcant. This lack of signiﬁcance of
the diﬀerent populations is demonstrated by the fact that they
do not reﬂect the results from the PMFs determined
previously.116 For instance, the symmetric TM5/6 interface
for μOR is given to be more stable than the TM1/2/H8 one
(Figure 4C), but it is not signiﬁcantly more populated.
According to the PMFs, an even larger population would be
expected for the TM1/2/H8 interface of kOR. Also of note is
the absence of the TM4 (or TM4/3) interface for the δOR,
while the TM4/5 is present. The PMFs indicated that they
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were not so dissimilar (Figure 4C).114,115 Finally, the TM3 and
TM7 were not involved in interfaces.
An interesting aspect of this last study from Provasi et al.85 is
the attempt to correlate the varying dynamics of the lipids
around the receptors with the interface-speciﬁc dimerization
rates (kon) in all systems. Their analysis suggests that the
heterogeneity of the lipid dynamics around the OR deﬁnes
diﬀerent zones of viscosity that in turn modulate the kinetics of
association of the receptors. They notably observed regions on
the surface of the receptors associated with “jammed” lipids
having extended persistent times, thereby preventing the
receptors from approaching each other. The authors argue
that this behavior may rationalize the absence of the TM5/6
symmetric interface in the case of μOR that we noted above.
This argument would actually be more general and reduce both
TM4/5 and TM5/6 interfaces, while TM1/2/H8 would be
favored kinetically. “Jammed” lipids were also observed in the
case of rhodopsin.81 In that case, they stabilized a metastable
state of the TM4/4 interface in which the interface was
lubricated by a layer of lipids.81 These kinetically trapped lipids
resulted in an energy barrier in the PMFs (Figure 4E) and
prevented the spontaneous association of rhodopsins.
In further studies it would be of great interest to investigate
the correlation between the heterogeneity of the lipid diﬀusion
(and the associated membrane viscosity) around the receptors
reported by Provasi et al., which suggests stronger lipid−
protein interaction, and the membrane deformation resulting
from the attempt of the membrane to compensate for the
hydrophobic mismatch between the lipid bilayer thickness and
the hydrophobicity of the protein surface. Periole et al. reported
varying heterogeneous membrane deformation around rhodop-
sin dependent on the membrane bilayer thickness80 and noted
the correlation between the locations of these deformations
with the protein contacts made during self-assembly simulation.
Such deformations were also reported for β1AR and β2AR and
their diﬀerences used to rationalize the oligomerization patterns
of these receptors based on the existence of a residual
hydrophobic mismatch,82 as discussed in the following section.
3.3. GPCRs Stability in LCP To Rationalize the “in Meso”
Crystallization
Khelashvili and co-workers used the Martini CGMD
approach80 to study the details of the interactions between
GPCRs and their environment in order to explain their
behavior in various lipid phases78,79 and identify forces driving
their assembly.82 Before engaging in actual Martini CGMD
simulations, Mondal et al. developed a method to characterize
and quantify the energy associated with membrane deforma-
tions around multihelical proteins using MD simulations at
atomistic resolution.100 The authors conﬁrmed the existence of
membrane thickness-dependent heterogeneous deformation
around the rhodopsin as reported earlier using Martini
CGMD simulations (Figure 3).80 They further used these
atomistic simulations to calibrate and validate a three-
dimensional continuum (CT) model referred to as 3D-
CTMD for its combination with MD. This model integrates
two key contributions to the energy cost of hydrophobic
mismatch between the protein and the membrane bilayer:117
the membrane deformation aiming at minimizing the mismatch
and the residual hydrophobic mismatch (RHM)the con-
tribution from an incomplete hydrophobic matching resulting
in energetically unfavorable exposure of the protein at the
protein−lipid interface. The energy term associated with RHM
is derived from the exposed surface area (extracted from the
MD simulation) and transfer energies between hydrophobic
and polar environments of protein residues. The authors
identiﬁed the free energy associated with RHM as a
contribution at least as important as the one from the
membrane deformation itself; both contribute to a few kBTs.
Furthermore, they showed that by averaging out the
deformations, the consideration of the radial heterogeneity of
the membrane deformation leads to an underestimation of the
actual contribution. They also show that the RHM contribution
varies with the helical segment of rhodopsin and suggest that
their relative contributions on TM1, TM2, TM4, and TM5 in
diﬀerent bilayer thicknesses would explain the contacts between
receptors observed in self-assembly simulations.80
Taking advantage of the increased sampling and system size
oﬀered by the Martini CGMD approach and its proven ability
to reproduce the system’s behavior observed at atomistic
resolution,100 Khelashvili et al.78 applied the 3D-CTMD
approach to rationalize the mechanism of “in meso”
crystallization, a method that recently became popular for
GPCRs. The challenge was to be able to simulate a receptor in
a lipidic cubic phase (LCP, Figure 2F) and lamellar phase long
enough to extract statistically signiﬁcant quantiﬁcation of the
hydrophobic/hydrophilic exposure of residues at the protein/
lipid interfacedata mandatory for the 3D-CTMD ap-
proach.100 Both systems could be simulated to convergence
using rhodopsin and monoolein as GPCR and lipid models,
respectively. The results revealed that the highly curved LCP
was actually able to accommodate better to the rhodopsin
radially inhomogeneous hydrophobic surface than the lamellar
phase, and thus, LCP reduced the residual hydrophobic
mismatch energetic cost. Rhodopsin is thus well accommodated
in an LCP environment. The authors further argued that
rhodopsin’s high cost for mobility in LCP will not be
counterbalanced by the low RHM and thus will favor a
monomeric state of the protein. In contrast, in the lamellar
phase the lower cost for mobility of the receptor and the higher
RHM would drive the system toward receptor oligomerization.
Although the mechanism of transition of the protein from the
LCP to the lamellar phase is not yet clear, the oligomerization
of the receptor in lamellar stacks may lead to bulk crystals as
well as other steps involved in the crystallization process, e.g.,
addition of precipitant.78
Of particular interest in this study is the identiﬁcation of
TM1 and TM5 as the regions on the rhodopsin surface with
higher residual exposure in the lamellar phase. Assuming that
hydrophobic mismatch is a driving force of protein
oligomerization in the membrane, this observation suggests
that these two regions would be primarily involved in protein
contact in the lamellar phase and thus in the crystals. This
hypothesis was supported by the analysis of GPCR crystal
structures issued from the in meso technology. Out of 14
protein−crystal contacts (from 12 structure ﬁles78) 10 use TM1
and/or TM5 in “canonical” interfaces in which the receptors
are parallel. It remains, however, to quantify to what extent the
diﬀerent receptors experience similar residual exposure on TM1
and TM5 as rhodopsin does in monoolein. Additional support
for this hypothesis comes from the self-assembly simulations of
rhodopsin in regular lipid bilayer, in which TM1 and TM5 were
found involved in the most prominent protein contacts.81 This
might also be the case for the δ-, μ-, and κ-opioid receptors as
discussed above and reported by Provasi et al.85 and for β1AR
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and β2AR reported by Mondal et al. (see below for more
details).82
In a subsequent study, Khelashvili and co-workers further
investigated the reasons for the success of the in meso
crystallization method. In this very well conducted work Johner
et al.79 ﬁrst characterized the geometrical features of the Pn3m
LCPs, such as mean curvature, surface area, and Gaussian
curvature of the midplane and water−lipid interface for
diﬀerent values of the lattice constant (dimension of the
lattice). They performed this characterization for three
monoacylglycerol (MAG) molecules with diﬀerent tail lengths:
14, 16, and 18 carbon atoms, 7.7, 7.9, and 9.9 MAG,
respectively. Besides validating their CG model of the lipid,
this analysis revealed the inhomogeneity of the lipid bilayer
properties in the LCP. Relevant here is the variation of the
membrane thickness reaching its thinnest level at the saddle
point of the LCP, where the proteins are thought to reside. The
authors went on by investigating the behavior of the adenosine
A2A receptor, A2AR, into a LCP built with 9.9 MAG. They
speciﬁcally looked at how a diﬀerent lattice constant could
accommodate A2AR and A2AR engineered with a thermo-
stabilized apocytochrome b562 from E. coli (M7W, TM102I,
K106L, referred to as BRIL118), A2AR-BRIL. The engineering of
the GPCR is key to the success on the in meso crystallization.
The values of lattice constant (82, 86, and 102 Å for A2AR and
102 and 113 Å for A2AR-BRIL) were selected to mimic the
eﬀect of the addition of precipitants, a critical step in the
crystallization process that reduces or increases the cell
dimension, thereby triggering the formation of crystals. The
lattice constant deﬁnes the cell dimension and thus the spacing
between the phases in the LCP. The results showed that both
A2AR and A2AR-BRIL were best accommodated in 9.9 MAG
with a lattice constant value of 102 Å (Figure 5), a setup used in
experiments to generate high-resolution structures.118 In other
conditions the system was either unstable (A2AR-BRIL/113) or
not optimal (A2AR/82 and 86). Importantly, in the 9.9 MAD/
102 setup both A2AR and A2AR-BRIL spontaneously located at
the saddle point of the LCP (Figure 5C−F) where the
membrane resembles the most a ﬂat lamellar bilayer. These
conditions were most energetically favorable to the system due
to the least disturbance of the LCP by the protein. An
additional important feature speciﬁc to the 9.9 MAG/102 set
up is the possibility for A2AR-BRIL to make contact with a copy
of the protein placed in the neighboring saddle point (Figure
5G). The contact made was similar to the one found in the
crystal (Figure 5G).118 In the context of the in meso
crystallization method, Johner et al. interpreted these results
as (i) the addition of precipitant (modifying the lattice
constant) would destabilize the GPCR in the LCP and
promote its migration to an adjacent lamellar phase and (ii)
the formation of contact between closely spaced copies of the
proteins in LCP (as seen for A2AR-BRIL) would possibly
promote the stacking of the protein before their migration to
the stacked lamellar phase. The results also rationalize the
dependence of the in meso success on the engineering (size,
shape, and orientation) of the GPCR.
3.4. β1 and β2 Adrenergic Receptors Oligomerization
Pattern
β1 and β2 adrenergic receptors (AR) are of particular interest
because these two receptors are highly similar (67% sequence
identity) but do experience distinct association patterns in the
membrane.119,120 Johnston et al.96 compared their interfaces
centered on TM4/3 (similar to the one named TM4 in their
previous study on δOR, see above and Figure 4B) and on
TM1/H8. The PMFs were this time obtained using Martini
CGMD simulations coupled to well-tempered metadynamics95
to augment the sampling (see Methods and Systems section).
The comparison of the PMFs of both receptors and for both
interfaces demonstrated the two receptors to behave identically
within the error bars, at odds with FRAP experiments giving a
more stable dimer for β2AR.
119 The PMFs also showed that for
both receptors the interface TM1/H8 is stronger than the
TM4/3. The authors interpreted the results as due to the fact
that the receptors might be diﬀusing as dimers associated
through the TM1/H8 interface and dimers of dimers would
weakly interact using other interfaces, e.g., TM4/3, thereby
Figure 5. A2AR and A2AR-BRIL in the lipidic cubic phase (LCP). Note
the spatial extension of the protein due to the insertion of BRIL, a
thermostabilized apocytochrome b562 from E. coli (M7W, H102I,
K106L).118 We show the water/lipid (wat/lip, blue) and membrane
midplane (midplane, red) for the A2AR in LCP with a lattice constant,
a, value of 82 (A and B) and 102 Å (C and D) and A2AR-BRIL with a
= 102 Å (E and F). One may appreciate how both A2AR and A2AR-
BRIL nicely ﬁt in the LCP with a = 102 Å; the membrane midplane is
at the center of the protein transmembrane section. (G and H) A2AR-
BRIL is shown in LCP with a = 103 and 113 Å to illustrate how a =
103 Å allows the protein protrusion (BRIL) to make contact with the
protein in the neighboring cell through the water channel. In a = 113
Å there is no contact. Adapted with permission from ref 79. Copyright
2014 American Chemical Society.
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reﬂecting the FRAP data.119 The similarity of the PMFs for the
two receptors also contrasts with a later work on these
receptors using the same CGMD technique and to which the
authors contributed. In that study signiﬁcant diﬀerences were
observed between β1AR and β2AR interactions with the bilayer
environment, consonant with experimental observations of
oligomerization patterns of β1AR and β2AR
82 (see the next
paragraph for more details). A possible explanation for this
discrepancy is the calculation of the PMFs for the TM1/H8
interface of β1AR and β2AR in which the contacts made by
TM1 face the side of TM7 instead of TM2 (TM1/H8* in
Figure 4B).
Mondal et al. applied their Martini CGMD/3D-CTMD
combination to the case of β1AR and β2AR.
82 In the case of
β2AR the authors show that the association between the
receptors reduces the energy penalty from residual hydrophobic
mismatch (RHM, Figure 6A). They further show that the
magnitude of the RHM reduction is a function of the part of
the protein involved in the contact, with TM1, TM4, and TM5
most aﬀected (Figure 6C). The analysis actually points to only
a few pertinent residues. The correspondence of these regions
with the most observed contacts formed in a self-assembly
simulation suggested once more that the RHM is a major
driving force toward the determination of protein contact upon
oligomerization. The authors then made the comparison with
the RHM found for β1AR, mainly pointing to TM1 as a hot
spot while strongly reduced on the TM4/5 interface compared
to β2AR (Figure 6B). This diﬀerence provides a potential
explanation for the oligomerization patterns of the two
receptors.119,120 β1AR would form mainly dimers at the TM1
interface, and β2AR higher order oligomers would form also
involving TM4 and TM5 (Figure 6).82 A detailed analysis
pointed to only a few residues to explain the diﬀerence in
RHM.
In further studies it would be interesting to conﬁrm this
hypothesis by looking at the contact zones of β1AR in a self-
assembly simulation. It would also be interesting to performed
self-assembly simulations of β2AR mutants lacking the residues
stabilizing the interfaces. The relevance of the few residues
pointed out by this study could also be tested by mutagenesis
experiments.
Ghosh et al. performed a self-assembly simulation of 16
copies of β2AR in a DSPC lipid bilayer.
84 Analysis of the
simulation showed an overall similar behavior as previously
described for other receptors.80−82,85 Notably, the receptors
form a string-like cluster (slightly more branched than for other
receptors, but it could result from a longer simulation time),
and the contact between receptors involves TM1, H8, TM5,
and TM6. There is one signiﬁcant diﬀerence in the simulations
of Ghosh et al. They did not use any restraints to maintain the
ternary structure of the helical bundle leading to a rmsd of
β2AR from 5 to 8 Å. These deformations are huge, and
although the helical bundle might still look like the original
receptor, it has certainly adopted a structure with signiﬁcant
diﬀerences. One needs to keep in mind that the active state of
β2AR is only ∼2.9 Å away from its inactive structure. (This
value was obtained by comparing the active and inactive states
of β2AR (restricted to residues 32−175, 179−230, and 265−
341) as found in 3D4S and 3SN6 PDB entries. A similar value,
2.85 Å, has been reported for rhodopsin.108) Figures 9 and S8
in the manuscript by Ghosh et al. illustrate these structural
diﬀerences. The ﬁgures depict a β2AR dimer formed during a
simulation and its comparison with the dimer found in a crystal
structure (PDB ID 3PXO108). In the CG dimer, one of the
Figure 6. Residual hydrophobic mismatch (RHM) at the β1AR and β2AR surface. (A) RHM for β2AR in monomeric and oligomeric states
illustrating the eﬀect of protein assembly in reducing the RHM and thereby the energy penalty. TM1, TM4, TM5, and TM7 are the most aﬀected.
(B) RHM for β2AR in a POPC lipid bilayer compared to the case of POPC with 10% cholesterol (chol) and for β1AR also in a POPC/chol bilayer,
showing the absence of eﬀect on the RHM by the addition of 10% chol and the large diﬀerence of RHM pattern between β1AR and β2AR. (C)
Projection of the contact frequency observed in self-assembly simulations of β2AR, reﬂecting the correlation between the zone of high RHM and of
protein contact formed. Reprinted from ref 82 with permission from Macmillan Publishers Ltd.: Copyright 2013.
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interacting monomers has H8 perpendicular to the membrane
plane. The authors interpreted the stabilization by ∼25 kcal/
mol of the TM1/H8 interface obtained in the Martini CGMD
simulation compared to the experimental model by the
requirement for “subtle rearrangement of the TM helices in
order to form proper oligomeric assemblies, which was
achieved through the CGMD simulation”. These structural
changes of H8 orientation are likely to be too drastic to be
realistic.
3.5. Cholesterol Involvement in GPCRs Assembly
Sengupta and co-workers used the Martini CGMD simulation
approach to study the interaction of cholesterol (chol) with
GPCRs and rationalize its eﬀect on their assembly. These
studies follow the extended work of Chattopadhyay on the
subject. Chol, a signiﬁcant component of biological membranes,
has been shown to play a critical role on membrane proteins
function121 and GPCRs supramolecular organization and
function,122−124 but its mechanism of action is still a matter
of debate. Chol would act directly on GPCRs through speciﬁc
interaction with the receptors125−128 or indirectly through
modiﬁcation of the membrane bilayer mechanical proper-
ties.123,129−131
In a ﬁrst study, Sengupta and Chattopadhyay132 charac-
terized the interaction pattern of chol with the serotonin1A
receptor (5-HT1AR). They ran Martini CGMD simulations of a
single receptor embedded into a 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) membrane bilayer contain-
ing 0%, 9%, 30%, or 50% chol. Overall, chol molecules interact
with, or explore, most of the receptor surface during the
simulations but spend the most time at, or bind to, speciﬁc
locations. Notably, one of these locations corresponds to one of
the three highly conserved chol recognition amino acid
consensus (CRAC) motifs.127 It is located on TM5. The
other two CRAC motifs were not observed arguably due to the
Figure 7. Illustration of the possible mechanisms of cholesterol stabilization of GPCR interactions, discussed for β2AR, but data for mGlu1 and S1P1
receptors are also depicted. (A) Stabilization of the TM1/H8 interface by favoring their contact: acting as glue between the interfaces. The presence
of cholesterol molecules in the crystal structure of β2AR
111 (Reprinted from ref 111 with permission. Copyright 2008 Elsevier.) and mGlu1112
(Reprinted from ref 112 with permission. Copyright 2014 AAAS.) and in simulations of S1P1
46 (Reproduced with permission from ref 46. Copyright
2015 American Chemical Society.) support this mechanism. (B) Destabilization of the TM4/5 interface by occupying a high-interaction site,83
thereby increasing the relative stability of the TM1/H8 interface. Schemes in A and B illustrate the change of relative free energy of the TM1/H8
and TM1/5 interfaces in the two mechanisms.
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exposure of these sites to the aqueous phase. Chol is found to
interact with 5-HT1AR on time scales from nanoseconds to
microseconds in the case of preferred occupancy sites. This
pattern of interactions is in line with the concept of
“nonannular” binding of chol to 5-HT1AR.
125 Nonannular
binding refers to lipids that do not frequently exchange with
other lipids in the bulk membrane.
In a subsequent work, Prasanna et al.83 studied the
interaction of chol with β2AR, a receptor also known to have
interactions with chol.110,111 Here, the authors used self-
assembly Martini CGMD simulation of a pair of receptors
embedded in a POPC lipid bilayer with 0%, 9%, 30%, or 50% of
chol. Analysis of these simulations led the authors to conclude
that the presence and increase of the chol content in the
membrane systematically aﬀects the interface the receptors use
to assemble. In the absence of cholesterol, β2ARs almost
exclusively interact in a symmetric manner though TM4/5.
With 9% and 30% chol, β2AR assembles less exclusively using
TM4/5 as TM1/2 gets involved. At 50% chol, β2AR switches to
an almost exclusive mode of assembly using TM1/2 in a
symmetric interface. The reported eﬀect of chol on the
interface of assembly is signiﬁcant, and the statistics are rather
convincing. To rationalize this eﬀect of chol, the authors
analyzed the chol occupancy at the seven helices of the
receptor. On the basis of their analysis the authors propose that
the presence of chol in the membrane prevents the use of
TM4/5 as an interface because it occupies an interaction site
located at the center of TM4. The occupancy site corresponds
to the position of a cholesterol molecule found in a crystal
structure.110,111
An interesting aspect of Prasanna et al.’s results is the
apparent contrast of the proposed mechanism of cholesterol
stabilization of β2AR dimer at the TM1/H8 interface by the
simulations with the one that could be suggested by inspection
of the β2AR structures.
110,111 From the crystal structure one
could speculate that chol stabilizes the TM1/H8 interface by its
location at the interface itself and thus acts as glue (Figure 7A).
This behavior has been suggested for other systems.133 In
contrast, the simulations point at an alternative mechanism by
which chol would favor the TM1/H8 interface by destabilizing
the TM4/5 interface. The latter is predominant in the absence
of chol (Figure 7B). The two mechanisms are, however, not
mutually exclusive. From the data presented, a stabilization of
the TM1 interface by direct interaction with chol cannot be
excluded. In fact, the occupancy of TM1 and TM2 at 50% chol
increases signiﬁcantly from the unbound to the bound receptor
situation (Figure 4 in ref 83). Other recent studies found chol
at the TM1/H8 interface of GPCR dimers.46,112
This eﬀect of cholesterol on GPCRs assembly is of great
biological and biophysical importance, and it might well be the
case that chol modulates the interfaces of β2AR by either or
both of the mechanisms described above (Figure 7). It is
informative to compare with the study from Mondal et al.82
based on a similar Martini CGMD approach and described
above. First, there is an apparent agreement. Speciﬁcally, both
studies give a mixture of TM1/2 and TM4/5 as the interface of
β2AR with 9% or 10% cholesterol for Prasanna et al.
83 and
Mondal et al.,82 respectively. The similarity of the residual
hydrophobic mismatch on β2AR reported by Mondal et al. for
0% and 10% chol may be reconciled with a large eﬀect on the
β2AR assembly pattern reported by Prasanna et al. since the
eﬀect of chol on the assembly of β2AR is by direct interaction of
chol with the receptor; thus, a modiﬁcation of the RHM might
not be required.
There are, however, a few points in the study of Prasanna et
al.83 that make the interpretation of the results not
straightforward. The lack of palmitoyl chains attached to the
receptor in Prasanna et al. might have an impact on the
interaction of cholesterol with the receptor and of the receptors
together.110,111 The pattern of increase of chol occupancy
described by the authors is not straightforward in the graph.
Most diﬀerences are within the error bars. Notable is the
mention of an increase of chol contacts with TM4 between
30% and 50% of chol. Other helices experience similar changes.
Moreover, the main diﬀerence in chol contacts is observed
between 9% and 30% chol, while the main diﬀerence of
interacting helices is observed between 30% and 50% chol
(Figures 3 and 4 in ref 83).
Of particular concern in the studies carried out by Sengupta
and Chattopadhyay is the lack of use of a protocol to maintain
the ternary structure of the GPCR. Most proteins deform
signiﬁcantly as the Martini CG force ﬁeld is not capable of
keeping the secondary and ternary structure without the use of
an elastic network. We illustrate this deformation on the
example of rhodopsin in Figure 1, which is in line with the work
of Horn et al.134 Such deformation was also reported for
another study of β2AR using the regular Martini force ﬁeld
without ElNeDyn (described above).84 Typically consecutive
helices reorient under the pressure of the environment, leading
to atomistic root-mean-square-deviations (rmsd) reaching ∼6−
7 Å. Such deformations should be considered as signiﬁcant at
the protein level. As a comparison, the rmsd between the
inactive and active receptors, which include an important helical
motion, is only ∼2.9 Å (see section 3.4 for more details). Visual
inspection of the graphical representations of β2AR in Prasanna
et al. (Figure 2 in ref 83) suggests signiﬁcant helix
reorientations. The deformations of the helical bundle might
well explain diﬀerences of interfaces observed with diﬀerent
amounts of chol in the membrane and may aﬀect interactions
with cholesterol as shown for rhodopsin.134
Despite these issues, simulating the eﬀect of cholesterol on
GPCRs assembly is of great biological and biophysical
importance and led Sengupta and Chattopadhyay to propose
a new paradigm135 in which the cholesterol interactions with
GPCRs would be described as a set of hot spots instead of
actual binding sites in an “undulating energy landscape
characterized by shallow minima with small energy minima”.
These “high occupancy sites” instead of strong interactions
would contribute to moderating GPCRs cross-talk and drug
eﬃciency.
During the reviewing process of this review, Prasanna,
Sengupta, and Chattopadhyay published their latest work on
the eﬀect of cholesterol on GPCRs oligomerization.136 In this
new study, Prasanna et al. follow up on their earlier work132 on
5-HT1AR discussed above. They applied their receptor self-
assembly strategy in POPC model bilayers with four chol
concentrations (0%, 9%, 30%, and 50%) described above in the
case of β2AR. The two papers are technically very similar, and
the overall conclusions for 5-HTA1R are very close to those
obtained for β2AR, namely, the presence of chol aﬀects the
mode of interaction of the receptors (their interface), and this
eﬀect depends on the concentration of chol. A few diﬀerences
are also noticeable. First, as described by the authors, in the
case of 5-HTA1R, the presence of chol seems not only to
destabilize the dimer interface (TM1) observed in pure POPC
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to favor diﬀerent interfaces, TM4/5 and TM5/6, but also to
weaken the interactions or their speciﬁcity quite signiﬁcantly.
This point is clearly illustrated by the absence of a predominant
interface in the presence of chol in the case of 5-HT1AR but not
for β2AR (compare Figure 3a−d in ref 136 to Figure 3a−d in
ref 132). The authors use this lack of preferred interface for 5-
HT1AR in the presence of chol to argue for a functional
modulation of the receptor interface plasticity by chol. Second,
and unfortunately not discussed by Prasanna et al., the
prominent interface observed in the 5-HTA1R dimer in the
absence of cholesterol, TM1/2, and destabilized by chol is the
same interface that is absent in the presence of chol and favored
by chol in the case of β2AR. Chol has thus an opposite eﬀect on
the two receptors. If this prediction were to be correct, it would
imply that cholesterol not only has the ability to aﬀect the
propensity and interface of GPCR oligomerization but also to
do so on a receptor-speciﬁc manner. This ability might well
constitute a natural strategy to selectively activate receptors
based on their lipid environment, which may vary dynamically
as a function of the cell membrane compartment they are
embedded in. Although this latest work of Prasanna et al. is
technically sound it is also tainted by the lack of any structural
restrains to maintain the ternary structure of the receptors. The
chol−receptors interactions might be impaired by the receptor
deformation.
In an even more recent study, Prasanna et al. investigated the
interactions of glycosphingolipids, the ganglioside GM1, with 5-
HTA1R.
137 GM1 is found to strongly interact with the protein
surface, showing preferential sites. Notably, GM1 is found to
bind at a consensus “sphingolipid binding domain” previously
described.138 This work is the ﬁrst computational study to
identify GM-GPCR interactions, and it illustrates the challenges
of acquiring proper statistics for complex membrane where
lipids stick to the protein more than POPC or cholesterol do.
Techniques allowing more eﬃcient sampling will be necessary
for such systems.
3.6. Receptors Distribution in a Plasma Membrane-Like
Bilayer
Sansom and co-workers contributed signiﬁcant studies to the
development and popularization of the Martini CGMD
approach for membrane proteins62−64,139 and their interactions
with the matrix.140−145 Notably, although they now routinely
Figure 8. Lipid molecules and their interactions with GPCRs. (A) High density of cholesterol on the surface of rhodopsin (PDB-ID 1U19) and
opsin (PDB-ID 3CAD; retinal free rhodopsin). Proteins are depicted by a colored tube following the trace of the backbone starting in blue at the N-
terminus to red at the C-terminus. Up to three binding sites are indicated per structure as white densities. Reproduced from ref 134 with permission.
Copyright 2013 Springer. (B) Cholesterol interaction sites found on 5-HT1AR at TM5. Two snapshots show two molecules of chol simultaneously
binding two diﬀerent sides of TM5. Reproduced with permission from ref 132. Copyright 2012 American Chemical Society. (C) Cholesterol
interaction sites on β2AR at TM4. Reprinted from ref 83 with permission. Copyright 2014 Elsevier. Top two representations depict the atomistic and
coarse grain conformation of the site as found in the structure.111 Lower bottom representations show four diﬀerent conformations to illustrate the
dynamics of the interaction observed in the CGMD simulations. Reprinted from ref 111 with permission. Copyright 2008 Elsevier. (D) Interaction
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use the Martini force ﬁeld and the ElNeDyn approach they
developed their own version of the protein force ﬁeld
independently and keep deriving new topologies146 to innovate
in modeling using Martini CGMD simulations.147
Recently, Koldso and Sansom studied the organization of
lipids and proteins in a mimic of the plasma membrane, PM, in
a couple of papers.46,148 In their most recent work,46 they
addressed the organization and the dynamics of a plasma
membrane model in three conditions: free of protein, PM
system, containing multiple copies of a single transmembrane
helix, gp130 system, the transmembrane domain of gp130, or of
a GPCR, the sphingosine 1-phosphate receptor 1, S1P1 system.
Up to now this set of systems is by far the more complex
simulated using a (pseudo) atomistic resolution. This would
not be possible with any other model than the Martini CG
model combined with MD simulations.
The plasma membrane model used has an asymmetric lipid
composition, PC:PE:Sph:GM3:chol and PC:PE:PS:PIP2:chol
in the outer and inner leaﬂets, respectively, with the ratio
40:10:15:10:25 and 10:40:15:10:25. In the system containing
gp130 and S1P1, 576 and 144 copies were inserted, respectively.
The three systems were simulated for 10 μs, leading to system
sizes after relaxation ranging from 104 to 125 nm.46 Although
the simulation length is arguably short (illustrated by the
unsteady evolution of the oligomer state of the proteins at 10
μs), their analysis led to extremely valuable information and
provided an unprecedented view of such biological system.
Koldso and Samson ﬁrst noted the reduction of the
membrane large-scale undulations observed in the PM system
to smaller magnitude ones in the gp130 system and mostly
absent in the S1P1 system. The possibility of a kinetic eﬀect
(due to the slowdown of the lipid lateral diﬀusion observed in
the presence of the proteins) was discarded since the diﬀusion
was aﬀected by a factor of ∼1.5 while the undulations by a
factor larger than 5 (estimated from the similarity of magnitude
at 2 and 10 μs in the PM and S1P1 systems, respectively).
Second, the lateral diﬀusion of the lipids in the simulations was
found reduced by the presence of the proteins and more within
the S1P1 system than in the gp130 system. The slowing down
of lipid dynamics in a crowded environment was predicted by
both experimental149,150 and computational85,144,151−153 stud-
ies, which suggested that the eﬀect is most pertinent for these
lipids interacting speciﬁcally with the proteins and thus moving
in tandem with them, leading us to the third observation in the
Koldso and Samsom work relevant to us here: the predominant
interaction of chol and PIP2 lipid molecules with S1P1. This
was ﬁrst notable by the larger reduction of their lateral
diﬀusion. The authors quantiﬁed these interactions by a contact
analysis revealing high contact frequency of PIP2 with basic
residues on the intracellular side and of chol with most
hydrophobic residues in the transmembrane span of S1P1
(Figure 8D). Both chol and PIP2 formed annular interactions
with S1P1.
46 The head of chol molecules formed more speciﬁc
contacts with the intracellular ends of TM1−3 and TM5−6
(Figure 8D). Interestingly, the authors reported the presence of
a cholesterol at the interface of S1P1 dimers when using TM1
as an interface (Figure 7A), and they discussed this observation
in the context of the previously suggested relevance of chol for
the stabilization of this interface in other GPCR, namely,
β2AR
111 and mGlu1.112 See below for more discussion.
Finally, the authors described the oligomerization pattern of
S1P1 in the PM. On a 10 μs time scale, they found S1P1 largely
as a monomer with transient formation of dimers, trimers, and
higher oligomeric states. The author noted the contrast of this
behavior with the one reported for rhodopsin,80,81 β2AR,
82
opioid,85 and A2A and D2
86 receptors where the receptors were
predominantly forming linear arrays or ﬁliform structures
(Figures 2 and 9). At this point it is not clear if this diﬀerence
results from (i) more dynamic or weaker receptor interactions
for S1P1, (ii) their slower lateral diﬀusion and yet unsteady
oligomeric distribution at 10 μs, or (iii) a competition between
protein−protein and protein−lipid interactions. As suggested,
Figure 9. Illustration of the preference of receptors’ surface for
docosahexaenoic acid (DHA). Guixa-̀Gonzaĺez et al. simulated 9 A2A
and 9 D2 receptors in rich and poor DHA lipid bilayers. (A)
Distribution of the receptors, A2AR (red) and D2R (blue), and DHA
(yellow) after 260 μs* CGMD simulation. One can appreciate the
aggregation of DHA at the surfaces of the 18 receptors. (B) Similar
picture as in A but comparing high and low levels of DHA in the
membrane. (C) Number of contacts in which the receptors are
involved as the simulations progress. (D) Average number of contacts
per receptors illustrating further the diﬀerent behaviors in rich and
poor DHA membranes. Reprinted from ref 86, Ramon Guixa-̀
Gonzaĺez, Matti Javanainen, Maricel Goḿez-Soler, Begoña Cordobilla,
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chol interactions might stabilize the S1P1 interactions but also
generate a kinetic barrier as proposed for opioid receptors.85 It
is also not clear how PIP2 is behaving. It might prevent the
receptors from approaching each other as Sengupta and co-
workers found chol behaving in the case of β2AR.
83
3.7. DHA Eﬀect on GPCR Oligomerization
Guixa-̀Gonzaĺez et al.86 recently used the Martini CGMD
approach to investigate the mechanism by which docosahex-
aenoic acid (DHA) may aﬀect the oligomerization of adenosine
A2A and dopamine D2 GPCRs. DHA is an omega-3
polyunsaturated fatty acid (PUFA) 22 carbons long with 6
double bonds. DHA has been shown to be essential for proper
brain function, and a low level of DHA in the brain was linked
to patients with mental154 and neurological disorders.155,156
Similarly, earlier studies reported the importance of DHA for
vision by aﬀecting the function of the visual photoreceptor
rhodopsin, a specialized GPCR.157−163 These two biological
processes have in common that they take place in cell
membranes with an extremely high DHA content: 40 and
60% of PUFA in cerebral gray matter164,165 and rod outer
segments (ROS) membrane, respectively.166,167 The reported
eﬀects of DHA on membrane biophysico-chemical properties
(ﬂuidity) combined with mounting evidence of the role of
GPCR oligomeric states to their function led the authors to the
hypothesis that DHA could aﬀect GPCR function by
contributing to GPCR oligomeric state stability. The existence
of A2A and D2 receptors oligomers
168−170 and the relevance of
their balance to neuropsychiatry171−174 combined with the low
level of DHA in patients with mental154 and neurological
disorders155,156 made them perfect candidates for this study.
Guixa-̀Gonzaĺez et al. combined Martini CGMD simulations
and bioluminescence resonance energy transfer (BRET)
experiments to investigate if and by which mechanism DHA
might aﬀect the assembly of A2A and D2 receptors. The study
consists mainly in the comparison of two conditions: low- and
high-DHA-content membrane models corresponding to a
disease-like and healthy-like patient, respectively. BRET
experiments did not detect a diﬀerence in receptors interactions
in low- and high-DHA-content membranes. In contrast,
receptors self-assembly simulations showed a clear increase
(∼20%) of receptor contacts in high- compared to low-DHA-
content membranes. The diﬀerence in time resolution of the
two approaches, microseconds for Martini CGMD and
milliseconds for BRET,86 led the author to propose that
DHA has a kinetic eﬀect on the receptor assembly. CGMD
simulations would capture this feature, while BRET would be
blind to it. They further analyzed their simulations to
characterize the mechanism by which DHA operates this
kinetic eﬀect.
The model membranes used in the protein self-assembly
simulations are complex mixtures aimed at reﬂecting general
brain lipid proﬁles. Healthy and diseased-like membranes
contained DPPC:DSPC:DOPC:SDPC:SM with ratios of
21:7:15:21:36 and 33:15:11:6:36, leading to 11% and 3% of
DHA (C22:6) chains, respectively. Both conditions contained
30% chol and nine copies of both A2AR and D2R (Figure 9A
and 9B).
The analysis of the simulations led the authors to the
following observations. First, the receptors arrange in a linear
array forming one or two contacts as reported for other
receptors in similar time scales.80−82,85 The author tested the
stability of this ﬁliform arrangement of the receptors on a
longer time scale, possibly the longest to date: 260 μs. The
receptors formed ﬁliform structures extending toward short-
branched arrangements (Figure 9A). Second, DHA avidly
surrounds the receptor surfaces (Figure 9A and 9B), which the
authors conﬁrmed by MD simulations at an atomistic
resolution and in line with results on rhodopsin.134,160,161,175
Third, in monomeric systems (only one protein) DHA
increases the lateral and rotational diﬀusion of the protein
but not of the lipids. Lipid diﬀusions, however, were lowered in
the crowded protein environment (18 proteins) with the
maximal eﬀect observed for SDPCthe most protein-
interacting lipid of the set present. These observations suggest
that the lipids are following the protein dynamics and most in a
crowded environment. Fourth, in a system with a higher DHA
concentration (31%, high-DHA), associated with a 3 times
increase of lateral diﬀusion, the author did not observe a faster
protein oligomerization rate. The proteins actually took longer
to associate. The authors interpreted these observations as the
ability of a healthy-like membrane to form local or partial phase
separation but not the high-DHA system. This local phase
separation (DHA prefers DHA lipids) would be a possible
mechanism for DHA to favor protein contacts in healthy
membranes. DHA-coated proteins would come together easier
in a locally/partially phase-separated system. Note, the authors
used the terminology “local phase separation” to describe a
phenomenon that would better be referred to as the formation
of local domains enriched in particular lipid types.
This mechanism of DHA action on the A2AR and D2R would
be diﬀerent than for rhodopsin where DHA was hypothesized
to shift the MI−MII equilibrium by making more free volume
available in the membrane and thereby the conformational
change associated with the formation of MII less costly
energetically.157,158,176
In summary, the increase of receptor oligomerization
observed in Martini CGMD simulations of healthy-like
membranes results from a combination of an increase of the
receptor translational and rotational diﬀusion, a decrease of the
membrane surface exploration of the receptor due to partial or
local phase separation (limited to DHA-rich regions), and an
increase of the eﬀective receptor-interacting diameter due to
DHA coating and thus able to sense each other at longer
distances.86
3.8. Lipids Interactions with Rhodopsin
Grossﬁeld and co-workers used the Martini CGMD simulation
approach to looking at lipid distributions and interactions
around rhodopsin.134 This study followed a couple of
publications on the subject using an atomistic resolu-
tion160−162,175,177,178 and inspired by a large set of experimental
data.98,122,124,131,157−159,176,179−191 These works characterized
the eﬀect of the various lipid components speciﬁc to the rod
outer segment (ROS) membrane and known to aﬀect the
function of rhodopsin. These eﬀects are often measured by
following the meta I−meta II (MI−MII) equilibrium, the last
two photointermediates of rhodopsin. Only MII is able to bind
its cognate G protein transducin. The MI−MII equilibrium is
sensitive to ROS membrane properties such as its lipid
headgroup composition (PC, PE, and PS), PUFA (DHA in
particular), and cholesterol contents. These eﬀects are nicely
summarized in a paper by Horn et al.134 and references therein.
In short, MII (active rhodopsin) is favored by an increase in the
negative curvature of the membrane (provided by PE and
DHA) and an acidic membrane surface (provided by PS). Chol
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favors MI, but its content decreases as the disks age (become
functional), and it stabilizes the disk membrane by compensat-
ing PE and DHA negative curvature.
Horn et al.134 built a Martini CG model similar the one they
used previously in atomistic MD simulations: a single receptor
embedded into a 2:2:1 molecular ratio of SDPC:SDPE:-
chol.160−162,175 This particular composition aims at mimicking
the ROS lipid composition.179,192−196 Two systems were
simulated: one with rhodopsin (based on the PDB ID
1U19197) and one with opsin, representing the activated
receptor (based on the PDB ID 3CAP106). In the activated
receptor, a conformational change involves the movements of
the cytoplasmic side of TM5 (inward) and TM6 (outward)
toward the helical bundle (Figures 8A, 10A, and 10B). They
performed 16 independent simulations of both systems each
1.6 μs, which represents an increase of system size by a factor of
∼3 and of simulation length by about 10 when compared to the
atomistic data. In their analysis, Horn et al. demonstrated on
many occasions the high degree of convergence of the sampling
performed, illustrating one of the powers of Martini CGMD
simulations: statistical signiﬁcance of complex systems.
Horn et al. performed detailed analysis of the simulations and
presented it in a very clear and convincing manner.134 The
Martini CGMD simulations basically conﬁrmed the trends
observed in the atomistic simulations161 but provided much
better statistics leading to conclusive observations. The
increased sampling also revealed chol interaction sites. First,
DHA chains are found with higher density at the protein
surface forming a ring. Second, stearoyl chains are excluded
from the ﬁrst shell into a second, most likely resulting from the
attachment of both DHA and stearoyl chains to a unique
headgroup. Third, a slight but statistically signiﬁcant preference
of PE headgroup was found for the protein surface with a
possible preferred region of interaction for rhodopsin close to
TM3/4/5 but less marked for opsin. Fourth, a cholesterol
binding site was observed at the TM1/H8 interface behind the
palmitoyl chains attached at Cys322 and 323 (Figure 8) in both
rhodopsin and opsin. It interacts vigorously with the palmitoyl
chains. This site corresponds to the location of cholesterol in
crystal structures of other GPCRs.110,111 Another site, found in
both systems, is located at the cytoplasmic side of TM3/4/5. It
was observed in atomistic simulations of adenosine A2A
receptor.198 A third site was found in opsin but not in
rhodopsin at the cytoplasmic end of TM5 and TM6. This
region is marked by a large conformational change of TM5/6
and ICL3. This emphasizes the sensitivity of the cholesterol
interaction with the receptor to the protein conformational
details. Overall, the clusters and residues involved in cholesterol
binding closely resemble the groups of residues identiﬁed in the
previous atomistic simulations.161 It should be noted that a
cholesterol interaction site at the cytoplasmic side of TM1/2/3,
previously identiﬁed by long atomistic simulations,177 was not
observed. Also, a few sites observed in β2AR and A2AR in
atomistic simulations were not found. It is actually not clear if
they should.
3.9. Stability of Experimental and Theoretical GPCR
Interfaces
During the reviewing process of this review, Baltoumas et al.199
published a study based on Martini CGMD simulations that
probe consistently GPCRs dimer interfaces derived from
experimental or theoretical approaches. The interfaces of visual
receptor rhodopsin, opioid, adrenergic and metabotropic
glutamate receptors, and CXCR4 receptors from diﬀerent
species were thus studied in a systematic manner, resulting in a
total of 21 systems simulated starting from known structures.
Overall, the authors describe that the structural diversity of
receptor interfaces found in experimental and theoretical
models reduces in the simulations to converge toward
consensus interfaces. The consensus conformations strongly
resemble the ones previously described in the literature for
Martini CGMD simulations, further emphasizing the relevance
of TM1/2/H8 and TM5/6 interfaces, and TM4/5 to a lesser
extent for GPCRs oligomerization. Most notably, the interfaces
“loosely packed” or containing cholesterol molecules rear-
Figure 10. Conformational heterogeneity in the TM5, ICL3, and TM6 region. Comparison of (A) two inactive rhodopsin (rho) structures, 1U19
and 2I35, and (B) inactive and active (rho*) rhodopsin, 2I35 and 2X72, respectively. Views from the membrane on TM6 and from the cytoplasmic
side are shown. (C) Steric clashes at the TM5/6 dimer interface with the inactive structure of rhodopsin (1U19, center) and active rhodopsin (2X72,
right). Dimer conformation built with the inactive rhodopsin structure 2I35 is shown for comparison (left). On this arrangement multiple salt
bridges are formed and shown by yellow links between negatively (green) and positively (blue) charged side chains. Zoom in of the region where the
interactions or the clash occurs is given for the three dimer’s arrangements.
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ranged signiﬁcantly, increasing protein contacts and minimizing
the involvement of chol while keeping similar receptors
orientation and improved protein packing. This study also
revealed the presence of hydrogen bonds and aromatic residues
(π−π) interactions at the interface of the receptors and close to
the membrane/water interface. Finally, correlations between
the dimer interfaces and regions of the receptors associated
with its function were found, suggesting a possible regulatory
mechanism of the function of GPCRs by their oligomerization
state.
4. LESSONS LEARNED
4.1. Methodological Insights: Pros and Cons of the Martini
CGMD Approach
In the ﬁeld of transmembrane proteins and most particularly for
GPCR, Martini CGMD simulations have revealed a multitude
of exciting ﬁndings in the extended range of size and time scales
inaccessible to traditional all-atom approaches. Not surprisingly,
these ﬁndings gravitated around the interplay between GPCRs
and the membrane matrix (length scale in which Martini
CGMD simulations excel) in relation to their oligomerization
and supramolecular organization and the involvement of
speciﬁc lipids (determinant for GPCRs).
The Martini CGMD simulations discussed in this review
illustrate the main advantage of the method: providing an
unprecedented view of the GPCRs embedded in membrane
bilayer in diﬀerent phases, enabling the rationalization of
experimental data and revealing new features. PMFs may reveal
the relative strength of interfaces between receptors, while self-
assembly simulations indicate the most accessible. The complex
composition of lipid bilayer allows unraveling preferences,
binding sites, and protein/membrane biophysical and bio-
chemical interplays.
There are, however, a few aspects of the method that are still
limiting and some that need to be considered carefully. We
discuss here the issues pertaining speciﬁcally to GPCR. General
issues of the Martini CGMD approach have been described
previously.24,28,48,200
4.1.1. Conformational Restriction: Needed To Avoid
the Collapse of the Receptor but Prevents Finding the
Most Stable Interface in a Particular Condition. The
conformational restriction imposed by the use of the ElNeDyn
approach65 is of great importance. We have shown in the
example of rhodopsin (Figure 1) that the regular Martini model
leads to a ∼6.5 Å rmsd of rhodopsin from the starting
conformation. Others have shown similar deformations for
β2AR
84 and rhodopsin.134 This magnitude of deviation will be
observed with any receptor and potentially any protein,
globular or integral. ElNeDyn keeps it within ∼2−2.5 Å
rmsd. Only a few exceptions have been reported, such as
mechano-sensitive channels.201
The drawback of the use of ElNeDyn is the actual
impossibility of modeling signiﬁcant conformational changes
of the protein. ElNeDyn does, however, include ﬂuctuations
relative to small changes and reproduces the plasticity of the
protein as an object.65 However, conformational changes such
as a receptor activation or even a loop conformational change
cannot be observed in the simulations. Filizola and co-workers
used a modiﬁed version of ElNeDyn where the force constant
of the EN applied to the loop regions was reduced to reproduce
the expected increased mobility. This approach, although
appealing, has to be used with precaution. Reducing the force
constant of the EN bonds as low as 250 kJ mol−1 nm−2 is not
appropriate in the Martini force ﬁeld. The bond may get so
weak that it gets overpowered by the local nonbonded forces
(LJ interactions), leading to the overlapping of consecutive
beads. In addition, the behavior of unstructured protein
segments in the Martini force ﬁeld has not been investigated
in terms of conformational ﬂexibility. The loop conformational
changes have thus to be considered with care. Alternatively, one
could use a recent approach proposing to derive dihedral
restrains from AA MD simulations to guide the conformational
search of small amino acid sequences.202 Work is in progress to
develop a Martini model with ﬂexible loop regions and more
generally a polarized ﬂexible backbone.203
Including conformational details of loop regions in the search
of GPCR interfaces is, however, important. One example lies in
the work of Johnston and Filizola on the opioid receptors
discussed in this review.116 They indeed observed a signiﬁcant
increase in the stabilization of the TM1/2/H8 symmetric
interface for kOR compared to any other GPCR reported
(Figure 4C and 4D). The outward pointing of TM1 from the
helical bundle was suggested to be the cause of this increase.
Another example of the sensitivity of the system to the protein
structure resides in the interactions of chol with rhodopsin and
opsin reported by Horn et al.134 The diﬀerent conformation of
the TM5/ICL3/TM6 region in the two structures allowed chol
to bind only to opsin (Figure 8A).
We illustrate this point further with the PMFs of an
alternative rhodopsin interface performed recently. We have
been curious about why the symmetric interface using TM5/
6found in the more recent structures of rhodopsin, opsin,
μOR, and κOR and found more stable than TM1/H8 in
μOR116was literally absent from our self-assembly calcu-
lations.81 The comparison of the structure used in self-assembly
simulations and the structure of opsin (Figure 10A) reveals the
presence of a steric clash that does not allow formation of the
interface observed in the latter structure. The clash occurs
between the intracellular loops 3 (ICL3) between TM5 and
TM6 (Figure 10C). The PMF calculated using a CG model
based on this alternative ICL3 conformation indicates that the
TM5/6 interface is more stable than the TM1/H8 one (Figure
4E).
Of potential interest in the search of alternative approaches
to ElNeDyn is the one coined Dom-ElNeDyn.204 In this
approach the EN to maintain the protein fold is decomposed in
domains. These domains do not share elastic bonds and are
thus free to move one relative to another. This could be used to
allow a section of the receptor to move, i.e., TM5 and TM6.
The techniques allowing heterogeneous ENs66 or the
combination of multiple ENs205 could also be advantageous.
4.1.2. Still Some Limitation on the System Size and
Time Simulated. Some of the simulations discussed in this
study have pushed the limits of computational approaches in
terms of both methodology and computer time dedicated to
them. However, it is amazing how the ﬁeld is evolving and that
the ﬁrst Martini CGMD simulations of GPCRs that contained
16 protomers simulated for 8 μs*80 can be already regarded as
relatively easy experiments. At the time it was performed it took
a couple of months on a supercomputer to be completed and
thereby represented a major achievement. Today one can run
this type of simulation without major investment. Nowadays,
major achievements consist of running systems containing from
481 to 946 times more proteins for about 1081 to 3086 times
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longer and in more realistic membrane systems containing
(many) diﬀerent lipids and protein types.45,46,206,207
Although the systems are getting bigger and more complex, it
is important to keep in mind that the biological processes that
the Martini CGMD approach allows one to tackle often happen
on longer time scales than actually currently simulated. A
typical example is the lack of bind/unbinding events in the self-
assembly simulation discussed in this review. One cannot
interpret the interface populations in terms of relative stability.
One has to perform PMF calculations in which the interfaces
are predetermined by restraining the relative orientation of the
proteins (see above). These simulations are quite costly and
tricky to perform, as one has to check the behavior of the
system in most windows within the range of receptor distances
explored with the umbrella sampling. The amount of sampling
(computer time) needed for reaching convergence in some
windows is signiﬁcant as the system might get kinetically
trapped, e.g., due to trapping of lipids. This approach has also
been suggested to overestimate the energetics208−210 when
sampling is not suﬃcient.
More realistic systems are also more computationally
demanding and therefore limited to a few tens of micro-
seconds.45,46
4.1.3. Providing More Resolution Using Multiscale
Approaches. The coarse grain resolution of the Martini model
poses a limitation since the details of the atomistic interactions
are lacking. When needed, atomistic resolution can be added
using so-called backmapping methods.211−214 The use of such
technique has been applied to reﬁne and/or validate protein/
lipid interfaces found by Martini CGMD simulations.96,215,216
Johnston et al. applied this approach213 to reﬁne CG structure
with GPCRs.96
4.2. General Biophysical Principles on Protein/Membrane
Interplay
4.2.1. Receptor-Induced Heterogeneous Membrane
Bilayer Deformations. The studies described above in
section 3 depict the interplay between the receptor and the
membrane lipid bilayer as a delicate mixture of forces where
speciﬁc, and possibly localized, lipid−protein interactions are in
balance with others, resulting from the mechanical properties of
the membrane matrix. Let us review here what these studies
have taught us on the general principles of protein−lipid
interactions.
The early studies on rhodopsin78,80 and later on β2AR
82 have
shown heterogeneous deformation of the membrane around
the receptors. These deformations are in perfect agreement
with simulations using atomistic resolution.100,217 Notably,
Mondal et al. showed that the assumption of a radially
symmetric deformation of the membrane at the protein surface
in their 3D-CTMD method would severely underestimate the
free energy cost of membrane deformation. They estimated the
eﬀect of heterogeneous deformation to almost 3 kBT.
100
The heterogeneity of the membrane deformations will
depend on the membrane properties itself. On the basis of
Martini CGMD simulations, we reported that the deformations
of the membrane bilayer at the surface of rhodopsin vary with
the membrane thickness (Figure 3A and 3B).80 Simulations
using an atomistic resolution conﬁrmed the delocalization of
the deformations with the membrane thickness (Figure 3C).100
In the Martini CGMD simulations the regions at the protein
surface where the lipid’s interactions with the protein would
deform the membrane the most correlate with the preferred
regions of protein−protein contact,80 in line with the concept
that hydrophobic mismatch contributes to the oligomerization
of membrane protein by reducing the energy cost due to
membrane deformation. Weinstein, Khelashvili and co-workers
extended this view by suggesting that in addition to the energy
cost due to membrane deformation, which actually seems
minimal for bilayers of physiological thickness,100 the presence
of residual hydrophobic mismatch (RHM, remaining hydro-
phobic mismatch due to incomplete matching by membrane
deformation) would contribute signiﬁcantly to the free energy
of the system.78,79,82,100 RHM results from the incomplete
hydrophobic matching between the membrane and the protein
when a too high cost for membrane deformation occurs or
when two consecutive helices have drastically diﬀerent
hydrophobic properties. This would leave regions of the
protein exposed to an unfavorable environment. They
proposed that in the case of β1AR and β2AR the diﬀerence of
RHM would explain their diﬀerent oligomerization pattern
observed experimentally.119,120 In the case of rhodopsin the
diﬀerence in RHM in lipid cubic and lamellar phases would
rationalize the recent success of the in meso crystallization
method.78,79 LCP reduces the RHM on rhodopsin, thereby
providing a stable environment. A subsequent destabilization of
the LCP would drive the receptors to a lamellar phase for
crystallization.
4.2.2. Lipid Trapping Results in Kinetic Barriers. Two
distinct types of interfaces were characterized in the case of
rhodopsin.81 One type of interface has a deep well at the
distance of contact and no free energy barrier to assembly, e.g.
TM1/H8, TM4/5, and TM5/6. The second type of interface
does not experience a signiﬁcant stabilization when formed and
shows a clear energy barrier to their formation. The analysis of
the simulations revealed the trapping of lipids at the interface
stabilizing a metastable state where the interface is lubricated by
a layer of lipids.81 In the case of opioid receptors, Provasi et al.
reported potentially related phenomena.85 They observed
heterogeneous lipid dynamics, and thus membrane viscosity,
around the receptors. They could correlate the zones of slow
lipids at the protein surface with low propensities (kon) of the
receptor to use that interface to assemble. The authors
interpreted this correlation as the presence of a kinetic barrier
to the formation of complexes with zones associated with
jammed lipids.
4.2.3. Evidence of Speciﬁc Lipid Binding Sites
Mediating Dimerization. Direct, speciﬁc, and localized
interactions of cholesterol molecules at the surface of receptors
have been reported in Martini CGMD studies for rhodopsin,134
5-HT1A,
132 and β2AR
83 (Figure 8). These interactions are in
l ine wi th repor t s us ing a tomis t i c MD simula -
tions,161,177,198,218−220 receptor crystal structures,110−112 and
experimental data. In their study on β2AR, Sengupta and co-
workers83 suggested that cholesterol, through occupying certain
locations on the protein surface with higher frequency, blocks
interfaces from engaging in protein−protein contacts. Given
the ubiquitous presence of cholesterol in biomembranes, this
blocking behavior of cholesterol is of general importance for
membrane protein complex formation. It would, therefore, be
important to consolidate this observation by ﬁnding other
occurrences of this behavior, maybe for other GPCRs. It is
notable that this “blocking” behavior is complementary to the
“gluing behavior” reported recently in the case of cardiolipin
acting as a glue between the proteins constituting the
respiratory chain complexes.133,207 A gluing behavior of chol
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would also be consistent with the ﬁnding of its tight binding at
the interface of GPCR dimer structures.110−112
4.2.4. Several Factors Contribute to GPCRs Self-
Assembly into Linear Aggregates. All the contributions
to receptor/membrane bilayer interplay described in the
Figure 11. Rhodopsin supramolecular organization in the rod outer segment (ROS) membrane. (A) AFM images (left) revealing the row-of-dimer
organization of rhodopsin in a native-like environment. Reprinted from ref 97 with permission from Macmillan Publishers Ltd.: Copyright 2003.
Images were used to extract structural restrains used to build a ﬁrst model of the rhodopsin dimer and dimer of dimers.101 It corresponds to the
TM4/5 model shown in B. Results from CGMD simulations (right) were used to build an alternative model based on the TM1/H8 dimer interface.
Reproduced with permission from ref 81. Copyright 2012 American Chemical Society. (B) Models of the rows-of-dimer organization of rhodopsin
according to diﬀerent dimer interfaces: TM1/H8, TM4/5, and TM5/6 interfaces corresponding to the most stable in the PMFs,81 the earlier model
build from the AFM images,101 and a potential alternative interface (Figure 4), respectively. (C and D) Binding mode of transducin (cognate G
protein of rhodopsin) to the three row-of-dimer models shown in B using (C) the canonical orientation (can, build from the β2AR-Gαs complex
structure232) and (D) an alternative orientation (alt233). See text for more details on the models. (E) Illustration of the pecking motion experienced
by G protein (Gt) that it might use during its search for activated rhodopsin to overcome physical barriers. Lipid bilayer is show in gray (aliphatic
chains) and blue (head groups). Gtαβγ trimer subunits are colored as α in green, β in red, and γ in yellow; full trimer is shown only every 8 μs*. α-
Helical C-terminus of Gtα (Gα/αCT) is colored in orange and depicted so that the magnitude (∼2 nm) of its pecking motion is visible.
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previous subsections result in forces that will aﬀect if not
govern the propensity for the receptors to remain as monomers
or to associate into dimers and higher ordered structures. Thus
far, all studies of GPCR using the Martini CGMD approach
show the receptors forming dimers and higher ordered
structures with the exception of the PM-like membrane
composition but again on a short time scale.46 The receptors
actually assemble with a predominance of linear arrays
(ﬁliform) structures80−82,84−86 with the appearance of some
small branched structures on a very long time scale.86 The most
straightforward explanation is the preference of the receptors to
interact through the “small” sides of the receptors: centered
either on TM1 or on TM5 (Figure 4). This behavior has been
most clearly demonstrated in the case of rhodopsin.81 It was
shown that the interfaces involving TM1/H8 and TM5 (TM5,
TM4/5) were found to be highly involved in the receptor
interfaces formed in self-assembly simulations. The PMFs as a
function of the receptor distance proved them to be much more
stable than the other interfaces.81 The interfaces involving TM4
(noted TM4/3 in other studies) and TM6 (TM6/7 might be a
better representation) were not observed upon self-assembly.
The PMFs of these interfaces revealed an energy barrier to their
formation and a metastable state in which lipids lubricate the
interface TM4. Linear aggregates are formed, most likely
because the short sides can form direct contacts whereas the
larger sides remain lubricated.
In their study of β1AR and β2AR, Mondal et al. rationalized
the ﬁliform organization of β2AR observed in self-assembly
simulations on the basis of the presence of residual hydro-
phobic mismatch (RHM) on the “small” sides of the receptors,
TM1/H8, and TM5 and not on the other larger sides.82 It is
not completely clear why the TM4/3 (also called TM4, see
Figure 4) interface was not found with a notable RHM and
more populated in the simulations since it was found to be
relatively stable and barrier free by Johnston et al.96
Furthermore, the RHM patterns on β1AR and β2AR allowed
Mondal et al.82 to rationalize the diﬀerent behavior of these
receptors in terms of oligomerization: while β1AR would mainly
form dimers, β2AR would engage in large and more dynamic
oligomers.119,120
In the case of opioid receptors, Provasi et al.85 also observed
ﬁliform structures mainly involving the small sides of the
receptors: centered on TM1 (TM1/2/H8) and TM5 (TM4/5
and TM5/6). Unfortunately, the authors could not conclude on
the relative strength of the interfaces formed. However, they
did describe a striking anticorrelation between the involvement
of an interface and the lipid dynamics (the membrane viscosity)
at that interface. In other words, they propose the existence of a
strong kinetics component in the determination of formation of
the receptor contacts in self-assembly simulations. The ﬂuidity
of the lipids or viscosity of the membrane bilayer is shown to
vary with the surface of the receptor and correlate with the
kinetic of formation of interfaces (kon). The more ﬂuid the
membrane, the more prompt the interface is to interact,
favoring small interfaces.
4.2.5. Protein Burial Is Not Appropriate for Measuring
Protein Interface Strength. The use of the protein burial
associated with a protein interface in the membrane environ-
ment as commonly done for globular complexes appeared not
to be a reliable tool to predict interface strengths. In the studies
discussed in this review on GPCRs, the stronger interfaces have
systematically a lower protein burial than weaker ones (Figure
4).81,96,116 This is at odds with common practice for soluble
proteins.221 It is likely that other forces are at play in membrane
proteins. Many are discussed in this review.
4.3. Toward the Role of a Row-of-Dimers Organization for
Rhodopsin Signaling
This highly ordered view of the rhodopsin organization is quite
compelling (Figure 11A). It is diﬃcult to imagine rhodopsin
freely diﬀusing as suggested by early biophysical experiments,
but this mobility has been the object of debate that is out of the
scope of this review.102 It is also quite challenging to imagine
transducin, Gt, rhodopsin cognate G protein, searching its way
to the receptors, ﬁnding the activated one, and thereafter
following the cascade of intracellular biochemical processes.
These aspects have been discussed previously.101,222−228 Here
we discuss novel aspects provided by Martini CGMD
simulations.
4.3.1. Row-of-Dimers Leads to a Unique Side of
Rhodopsin Exposed to Bulk Membrane. One direct
consequence of the highly symmetric supramolecular organ-
ization of rhodopsin that is not often considered in the
functional models is that it leaves only one side of rhodopsin
exposed to the membrane bulk, discarding the ends of the rows.
If one wants to consider an alternative model as the sliding of
Gt along the row-of-dimers,226 the side of rhodopsin exposed to
the membrane bulk is of great interest. It would be the only
side viewed by Gt approaching. This exposed face is entirely
determined by the conformation of the intra or functional
dimer (Figure 11B), emphasizing the importance of the search
for the main interface for rhodopsin and potentially other
GPCRs. In such organization, the search of Gt for an activated
receptor, rho*, is radically simpliﬁed. It would ensure that Gt
approaches the receptor by the same side. Note that the
exposed side is not necessarily the one to bind, but it might
contain the recognition side for Gt to engage in the binding
mechanism.
In regard to the Gt search of an activated receptor, it is
interesting to note the pecking motion observed in Martini
CGMD simulation (Figure 11E). This motion allows the C-
terminus of its α-subunit, which binds the receptor within the
groove open upon activation, to go over potential physical
barriers on the order of 2−3 nm from the membrane surface
(Figure 11E). In the mean time, Gt is anchored to the
membrane by its post-translational lipid modiﬁcation of its α
and γ subunits (Figure 11).
4.3.2. Row-of-Dimer with the TM1/H8 Dimer Struc-
ture. On the basis of the Martini CGMD simulation work on
rhodopsin we built a structural model following the row-of-
dimer arrangement reported from AFM images and satisfying
the cell dimensions determined from these images of rhodopsin
in disk membrane prepared from mouse retina (Figure 11).97
The duality of the interfaces (strong vs weak and lubricated,
Figure 4E) ﬁtted perfectly a model of rhodopsin organized in
rows-of-dimers (Figure 11A). The stronger interface, TM1/H8,
was used as the main dimer interface (intra) and the weak ones,
TM4 and TM6, were used in between the dimers (inter) in a
row (Figure 11B). Using the TM1/H8 interface as the main
dimer interface was supported by its strength81 and its presence
in the ROS membrane.109 This model satisﬁes the structural
restrains extracted from the AFM images (Figure 11A and
11B).81
This model diﬀers from the model proposed earlier by the
authors of the AFM images, which utilizes the TM4/5 interface
for the intradimer contact (Figure 4) and TM2 and TM6 for
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the interdimer contacts.101,226 Functional models have been
derived from this particular arrangement.101,226,227
4.3.3. TM5/6 Interface a Possibility for Rhodopsin? In
searching for potentially stable interfaces for rhodopsin,81 the
TM5/6 did not appear as a potential candidate. It was only
recently observed in an experimental structure of μOR229 and
was shown to be more stable than the TM1/H8 interface for
μOR based on a PMF study using Martini CGMD
simulations.116 It was also reported to spontaneously form in
self-assembly Martini CGMD simulations of homo- and
heterodimeric interfaces of opioid receptors.85 Also of potential
interest is its involvement in a rearrangement of the interface of
a family C GPCR.230 The question is why did not the TM5/6
interface form in our extensive self-assembly simulations of
rhodopsin?81
As quickly discussed above, the construction of a model of a
rhodopsin dimer reﬂecting the TM5/6 interface found for μOR
(PDB ID 4DKL229) revealed a severe clash between the ICL3,
the intracellular loop between TM5 and TM6, of the rhodopsin
model structure used in our Martini CGMD simulations (based
on PDB ID 1U19197). Among the rhodopsin structures
deposited in the PDB, the most recent structures have an
alternative conformation of TM5/ICL3 with an additional
helical turn on the cytoplasmic side of TM5 and a diﬀerent
conformation of ICL3 (PDB ID 1GZM231 and 2I35107). Using
such conformation for TM5/ICL3 (based on PDB ID 2I35) in
a new CG model of rhodopsin in the dimer arrangement
reﬂecting the TM5/6 orientation indicates the disappearance of
the steric clash between ICL3 (Figure 10C). The determination
of the PMF of that clash-free interface demonstrated an
intriguing stability of the TM5/6 interface (Figure 4E). The
interface seems stabilized by a double salt bridge on the
cytoplasmic side (Figure 10C), leading to a more stable
interface than the TM1/H8 one, also shown for μOR.116
At this point it is not clear how the dimer based on the
TM5/6 interface could accommodate the conformational
change associated with rhodopsin activation. There would be
a steric clash between the two monomers upon activation of
one of them (Figure 10B and 10C). To avoid the unfavorable
overlap, the movement of TM5 and TM6 upon rhodopsin
activation would have to trigger either the dissociation of the
dimer or its reorganization. Such reorganization is possible and
has been recently proposed to explain FRET data for the
metabotropic glutamate receptor.230
4.3.4. Gt Binding to Rhodopsin in the Row-of-Dimers
with Diﬀerent Dimer Interface. Here, we search for
structural clues from looking at how Gt ﬁts on the rows-of-
dimer models built with diﬀerent rhodopsin interfaces. For this
exercise we use the three most popular rhodopsin interfaces,
TM1/H8 (stable in Martini CGMD simulations, seen in crystal
structures and observed in ROS membrane), TM4/5 (built
from AFM images and cross-link experiments), and TM5/6
(stable in Martini CGMD simulations and observed in crystal
structures), and two activated rhodopsin/transducin complexes
(rho*/Gtαβγ): one built according to the β2AR/Gs struc-
ture,232 the canonical model (rho*/Gtcan), and an alternative
orientation,233 rho*/Gtalt. The later model was built prior the
publication of the β2AR/Gs complex, and we use it here as an
alternative model for a conceptual purpose.
The Mukhopadhyay et al.233 motivation for building this
alterative model, rho*/Gtalt, originates in that the structural
model of opsin in complex with a variant of the C-terminus of
alpha-subunit of Gt suggested a strong clash between Gtαβγ·
GDP and the membrane bilayer, which was then interpreted by
a large packing change of the alpha5 helix of Gt upon signal
transduction from rhodopsin.234 Mukhopadhyay et al. built the
rho*/Gtαβγ·GDP from bits and pieces using available high-
resolution structures (see Mukhopadhyay et al.233 for details).
The main diﬀerence between the rho*/Gtcan and the rho*/Gtalt
is a rotation of the whole Gtαβγ by about 120° relative to rho
while keeping the C-terminus of Gtα bound to rhodopsin. This
rotation displaces the N-terminus helix of Gtα from the groove
in between TM2 and TM4 (ICL1 and ICL2) in rho*/Gtcan to
the groove between TM4 and TM5 (ICL2 and ICL3) in rho*/
Gtalt.
The three row-of-dimer models are depicted together with
the original AFM images97 and a model resulting from a
Martini CGMD study81 (Figure 11A and 11B). The relative
orientation of the receptors can be appreciated by H8
highlighted in orange. The comparison of the three models
free of Gt leads to interesting observations. The ﬁrst concerns
the distribution of rhodopsin protrusions (TM6) marked by
yellow transparent spheres in Figure 11B. While TM1/H8
(3.87 and 4.76 nm) and, to a lesser extent, TM4/5 (3.75 and
5.15 nm) models are close to the experimental distances97 (3.8
and 4.2 nm) distribution (Figure 11A), the model TM5/6
(3.91 and 1.97 nm) is not. The protrusions are too close.
Second, the relative orientations of the pairs of dots in a dimer
along rows in TM1/H8 and TM4/5 models indicate that while
TM1/H8 respects the alignment found in the AFM images (γ =
85), TM4/5 does not. TM4/5 would have a left shift (γ = 95).
Thus far the TM1/H8 model seems thus to be the best
candidate.
The accommodation of rho*/Gtcan and rho*/Gtalt by the
three models also provides interesting observations (Figure
11C and 11D). We will work here with two assumptions: one is
that the lipid anchors of Gt (post-translational modiﬁcation on
the N-terminus of Gtα and C-terminus of Gtγ) should be
embedded in the membrane bulk or close to it; the second is
that the functional complex involves possibly a dimer of
rhodopsin but not exclusively.235−237 In the case of Gtcan, only
the TM5/6 model puts Gt lipid anchors in the bulk membrane.
In the same TM5/6 model, some of Gtα would interact with
the second monomer of the intradimer. In the TM1/H8 and
TM4/5 models, the Gtcan places its lipid anchors at least
partially on top of the neighboring rhodopsin in the next dimer
(Figure 11C) as most of Gtα and Gtβ. Gtalt is intriguing
because although it has a ∼120° rotation of Gt compared to the
canonical binding, this rotation makes the TM1/H8 model a
good candidate. Notably, it places Gt lipid anchors into the
membrane bulk and removes clashes of Gtβ with the
neighboring rhodopsins dimer. In the cases of TM4/5 and
TM5/6 models, the lipid anchors would again be at least
partially on top of the neighboring dimers. In the case of the
TM4/5 model, the Gtalt binding mode places Gtαβγ in
interaction with the rhodopsin dimer in an apparent alignment.
As a note, it is interesting to mention that if we had
considered only a single rhodopsin dimer all interfaces and Gt
binding modes would have accommodated Gt lipid anchors in
the membrane bulk and only Gtalt bound to TM4/5 would have
had important contact (potential clash) with the partner
rhodopsin. The others would possibly accommodate Gt
without major contact with the second receptor.
In summary, the analysis of Gt binding using two modes
onto three models of rhodopsin in a row-of-dimer arrangement
does not lead to convincing observations pointing to a most
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likely complex. All have at least a major improbable feature.
This leaves us with the possibility that the rhodopsin might
change its interface between active and inactive states, in a
similar fashion as recently reported for another receptor.230 The
activated metarhodopsin could break the row-of-dimers and
dissociate from it as a monomer that binds and activates
transducin. However, no evidence has pointed to such a
mechanism for rhodopsin.
4.4. Insights into the Oligomerization State of
non-Rhodopsin GPCRs
The set of studies reviewed in this manuscript has unfortunately
not brought many conclusive data on the actual oligomerization
or supramolecular organization of GPCRs. It results from the
relatively limited time scale of the simulations (maximum to
date, 260 μs*) during which mostly assembly of receptors has
been reported leading to linear or short-branched structures.
Only studies using more complex membranes to mimic native
lipid composition seem to picture GPCRs (S1P1) as more
dynamic but so far only from simulations with short time
scale.46 In the case of rhodopsin, expected to be highly ordered,
the Martini CGMD simulations have not reported the
spontaneous formation of such organization in the time scale
accessible. The studies of non-rhodopsin GPCRs have however
been able to provide clear preferences for certain interfaces
leading to rationalization of experimental observations.
An interesting aspect of the range of interface strengths
among the GPCRs tested (Figure 4) is the relative similitude of
the interfaces probed. Only a few exceptions are markedly
diﬀerent and possibly not realistic. This is in contrast to
rhodopsin, which seems to have a more discrete and deﬁned set
of interfaces (Figure 4). This diﬀerence might reﬂect the more
general idea that GPCR oligomers are more dynamic while
rhodopsin is more ordered.
5. CONCLUDING REMARKS
Overall, the studies described in the review represent an
extremely valuable set of simulations of GPCRs. They reveal
ways of GPCRs to interact with a membrane lipid bilayer,
forces that aﬀect their behavior as monomers, and trigger them
to form oligomers and higher order structures, leading to new
hypotheses for better functional models and inspiring the
design of new experiments to probe them. We can only wish to
get similar data for more GPCRs and extracted more
systematically in order for them to be more conclusive when
combined. These studies also highlighted generic protein/lipid
interplays that should extend to membrane protein biophysics
in general.
It makes no doubt that the membrane environment is a very
complex media238 that goes beyond the original ﬂuid mosaic
model239 and that Martini CGMD simulations will be an
essential tool in uncovering the principles governing this
fundamental challenge in biological chemistry.240 The nature of
the data produced by this method will increase in complexity to
become closer and closer to realistic membrane compositions
with time scales reaching experimental observables. It is
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